Personnel Information

写真a

FUJII Yasuhisa


Job title

Professor

Birth date

1963

Research Areas, Keywords

Genitourinary cancer, prostate cancer, kidney cancer, bladder cancer, urothelial cancer

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1988.03, Graduated

Campus Career 【 display / non-display

  • 1988.04
    -
    1988.06
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, research fellow
  • 1988.06
    -
    1988.12
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Trainee Resident
  • 1995.07
    -
    1996.06
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Senior Resident
  • 1996.07
    -
    2004.03
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Assistant Professor
  • 2004.04
    -
    2005.09
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Junior Associate Professor
  • 2007.07
    -
    2010.07
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Junior Associate Professor
  • 2010.07
    -
    2011.06
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Associate Professor
  • 2012.07
    -
    2016.07
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Associate Professor
  • 2016.08
    -
    2017.12
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Professor
  • 2018.01
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Professor
  • 2018.04
    -
    2019.04
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Professor
  • 2019.05
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Professor

▼display all

External Career 【 display / non-display

  • 1989.01
    -
    1989.12
    , Trainee Resident

Academic Activity 【 display / non-display

  • Japanese Journal of Clinical Oncology REVIEWER

Research Areas 【 display / non-display

  • Urology

 

Research Theme 【 display / non-display

  • Bladder cancer

  • Kidney cancer

  • Prostate cancer

Published Papers & Misc 【 display / non-display

  1. Takahiro Osawa, Mototsugu Oya, Tohru Okanishi, Ryohei Kuwatsuru, Haruna Kawano, Yoshihiko Tomita, Yo Niida, Norio Nonomura, Takashi Hatano, Yasuhisa Fujii, Masashi Mizuguchi, Nobuo Shinohara. Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update. Int J Urol. 2023.10; 30 (10): 808-817. ( PubMed, DOI )

  2. Julia H Yuan, Hajime Tanaka, Dattatraya Patil, Kevin Hakimi, Shady Soliman, Margaret F Meagher, Ava Saidian, Arman Walia, Sohail Dhanji, Franklin Liu, Jonathan Afari, Mimi Nguyen, Luke Wang, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 2023.08; 21 (4): e219-e227. ( PubMed, DOI )

  3. Takahiro Osawa, Yasuhisa Fujii, Go Kimura, Hiroshi Kitamura, Yoji Nagashima, Sakura Iizumi, Tsuyoshi Osaka, Ryoichi Tsubouchi, Nobuo Shinohara. Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care). BMJ Open. 2023.07; 13 (7): e070275. ( PubMed, DOI )

  4. Yuki Mizuno, Soichiro Yoshida, Kentaro Okamoto, Yasuhisa Fujii. Utility of an endoscopic image processing system for framing laparoscopic images using surgeon's gaze point and voice commands during laparoscopic percutaneous extraperitoneal closure of inguinal hernia in children. Wideochir Inne Tech Maloinwazyjne. 2023.06; 18 (2): 372-377. ( PubMed, DOI )

  5. Hisamitsu Ide, Yuko Akehi, Shinichiro Fukuhara, Shin Ohira, Sumito Ogawa, Tomoya Kataoka, Hiroshi Kumagai, Ko Kobayashi, Akira Komiya, Kazuyoshi Shigehara, Takahiro Syuto, Jintetu Soh, Makito Tanabe, Hisanori Taniguchi, Koji Chiba, Kazuhito Matsushita, Yozo Mitsui, Takahiro Yoneyama, Tomoya Shirakawa, Yasuhisa Fujii, Hiroaki Kumano, Hajime Ueshiba, Toshiyasu Amano, Haruaki Sasaki, Seiji Maeda, Atsushi Mizokami, Kazuhiro Suzuki, Shigeo Horie. Summary of the clinical practice manual for late-onset hypogonadism. Int J Urol. 2023.05; 30 (5): 422-430. ( PubMed, DOI )

  6. Toshiki Kijima, Shohei Fukuda, Hiroshi Fukushima, Sho Uehara, Yosuke Yasuda, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma. Jpn J Clin Oncol. 2023.04; 53 (5): 436-442. ( PubMed, DOI )

  7. Soichiro Yoshida, Taro Takahara, Yuki Arita, Masaya Ito, Sara Hayakawa, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Takeshi Yuasa, Masaharu Inoue, Hiroki Ushijima, Shigehiro Kudo, Yasumasa Shimano, Yuki Nakamura, Yusuke Uchida, Sho Uehara, Hajime Tanaka, Hiroshi Yaegashi, Kouji Izumi, Minato Yokoyama, Yoh Matsuoka, Yasuo Yoshioka, Koji Konishi, Katsuyuki Nakanishi, Akira Nagahara, Akihiro Hirakawa, Ryuji Koike, Fumitaka Koga, Kazuo Nishimura, Atsushi Mizokami, Junji Yonese, Yukio Kageyama, Ryoichi Yoshimura, Yasuhisa Fujii. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL). BMC Urol. 2023.03; 23 (1): 33. ( PubMed, DOI )

  8. Yujiro Nakano, Masanori Murakami, Kazunari Hara, Tatsuya Fukuda, Masato Horino, Akira Takeuchi, Yoshihiro Niitsu, Kumiko Shiba, Kazutaka Tsujimoto, Chikara Komiya, Minato Yokoyama, Kenji Ikeda, Takanobu Yoshimoto, Yasuhisa Fujii, Tetsuya Yamada. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease. Clin Endocrinol (Oxf). 2023.03; 98 (3): 323-331. ( PubMed, DOI )

  9. Yuki Arita, Soichiro Yoshida, Keisuke Shigeta, Thomas C Kwee, Hiromi Edo, Naoko Okawara, Masahiro Hashimoto, Ryota Ishii, Ryo Ueda, Shuji Mikami, Motohiro Fujiwara, Yuma Waseda, Eiji Kikuchi, Yasuhisa Fujii, Masahiro Jinzaki. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. Eur Urol Oncol. 2023.02; 6 (1): 99-102. ( PubMed, DOI )

  10. Nishizawa M, Kudo T, Kijima T, Fujii Y. Failed endovascular abdominal aortic aneurysm repair due to Mycobacterium bovis infection following intravesical bacillus Calmette-Guérin therapy. J Vasc Surg Cases Innov Tech. 2022.12; 8 (4): 807-812.

  11. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; ( PubMed, DOI )

  12. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

  13. Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed, DOI )

  14. Tanaka H, Fujii Y. Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma Int J Urol. 2022.08;

  15. Arita Y, Yoshida S, Shigeta K, Kwee TC, Edo H, Okawara N, Hashimoto M, Ishii R, Ueda R, Mikami S, Fujiwara M, Waseda Y, Kikuchi E, Fujii Y. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology Jinzaki M.Eur Urol Oncol (IF: 2.51; Q1). 2022.08;

  16. Miyauchi M, Akashi T, Furukawa A, Uchida K, Tamura T, Ando N, Kirimura S, Shintaku H, Yamamoto K, Ito T, Miura K, Kayamori K, Ariizumi Y, Asakage T, Kudo A, Tanabe M, Fujii Y, Ishibashi H, Okubo K, Murakami M, Yamada T, Takemoto A, Bae Y, Eishi Y, Ohashi K. Endocr Pathol. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma Endocr Pathol. 2022.08; 33 (4): 506-518.

  17. Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab Asia Pac J Clin Oncol (IF: 2.6; Q4). 2022.08;

  18. Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clin Genitourin Cancer. 2022.08; 20 (4): 276-282.

  19. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma BJU Int. 2022.07;

  20. Tanaka H*, Fujii Y. Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review Int J Urol. 2022.06;

  21. Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation Abdom Radiol (NY) (IF: 3.04; Q2). 2022.06;

  22. Meagher MF, Patil D, Saito K, Javier-Desloges JF, Bradshaw AW, Patel SH, Cotta BH, Yasuda Y, Eldefrawy A, Ghali F, Nasseri R, Wan F, Fujii Y, Master V, Derweesh IH. Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC) Urology. 2022.05; 163 164-176.

  23. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy Urol Oncol (IF: 3.5; Q3). 2022.04;

  24. Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel). 2022.03; 12 (4): 817.

  25. Yoshida S, Matsushima H, Fujii Y. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity World J Urol (IF: 4.23; Q1). 2022.03;

  26. Yoshida S, Fujii Y. Editorial Comment from Dr Yoshida and Dr Fujii to Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: A diagnostic meta-analysis Int J Urol (IF: 3.37; Q2). 2022.03;

  27. Arita Y, Yoshida S, Kwee TC, Edo H, Kufukihara R, Shigeta K, Nagasaka M, Takeshita R, Okamura H, Ueda R, Ishii R, Okuda S, Fujii Y. Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination Eur J Radiol (IF: 3.53; Q2). 2022.03;

  28. Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer Eur Radiol (IF: 5.32; Q1). 2022.02;

  29. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response 2022.01;

  30. Cathrine Keiner, Margaret Meagher, Dattatraya Patil, Kazutaka Saito, Arman Walia, Franklin Liu, Raksha Dutt, Nathan Miller, Sohail Dhanji, Ava Saidian, Fang Wan, Yosuke Yasuda, Yasuhisa Fujii, Hajime Tanaka, Viraj Master, Ithaar Derweesh. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Front Oncol. 2022; 12 995991. ( PubMed, DOI )

  31. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Fujiwara M, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy Int J Urol. 2022;

  32. Preedanan W, Suzuki K, Kondo T, Kobayashi M, Tanaka H, Ishioka J, Matsuoka Y, Fujii Y, Kumazawa I.. Improvement of Urinary Stone Segmentation Using GAN-Based Urinary Stones Inpainting Augmentation. IEEE Access. 2022;

  33. Tanaka H*, Fukuda S, Kimura K, Fukawa Y, Yamamoto K, Fukushima H, Moriyama S, Yasuda Y, Uehara S, Waseda Y, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Tateishi U, Campbell SC, Fujii Y. . Defining tumour shape irregularity for preoperative risk stratification of clinically localised renal cell carcinoma Eur Urol Open Sci. . 2022;

  34. Yuan JH, Tanaka H, Patil D, Hakimi K, Soliman S, Meagher M, Saidian A, Walia A, Dhanji S, Liu F, Afari J, Nguyen M, Wang L, Yasuda Y, Saito K, Fujii Y, Master V, Derweesh IH. . Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 2022;

  35. Rossi SH, Tanaka H, Usher-Smith JA, Bernhard JC, Fujii Y, Stewart GD. . Kidney Cancer Screening and Epidemiology Société Internationale d’Urologie Journal.. 2022;

  36. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

  37. Kazunari Hara, Masanori Murakami, Yoshihiro Niitsu, Akira Takeuchi, Masato Horino, Kumiko Shiba, Kazutaka Tsujimoto, Chikara Komiya, Kenji Ikeda, Mika Tsuiki, Akiyo Tanabe, Toshihiro Tanaka, Minato Yokoyama, Yasuhisa Fujii, Mitsuhide Naruse, Tetsuya Yamada. Heterogeneous circulating miRNA profiles of PBMAH. Front Endocrinol (Lausanne). 2022; 13 1073328. ( PubMed, DOI )

  38. Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

  39. Soichiro Yoshida, Yasuhisa Fujii. MRI-Targeted Biopsy in Prostate Cancer Screening. N Engl J Med. 2021.11; 385 (22): 2110. ( PubMed, DOI )

  40. Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hirotaka Akita, Shigeo Okuda, Yuki Iwaita, Kiyoko Mukai, Shunya Matsumoto, Ryo Ueda, Ryota Ishii, Ryuichi Mizuno, Yasuhisa Fujii, Mototsugu Oya, Masahiro Jinzaki. Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma. Eur J Radiol. 2021.10; 143 109895. ( PubMed, DOI )

  41. Riko Maruyama, Hiroshi Fukushima, Shohei Fukuda, Yosuke Yasuda, Sho Uehara, Hajime Tanaka, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. Int J Urol. 2021.10; 28 (10): 1032-1038. ( PubMed, DOI )

  42. Minato Yokoyama, Junichiro Ishioka, Mikayo Toba, Hiroshi Fukushima, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Masumi Ai, Kiyohide Fushimi, Yasuhisa Fujii. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018. Int J Urol. 2021.09; ( PubMed, DOI )

  43. Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed, DOI )

  44. Wataru Shimada, Hajime Tanaka, Yuki Fukawa, Koichiro Kimura, Kouhei Yamamoto, Shohei Fukuda, Hiroshi Fukushima, Yosuke Yasuda, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. Int J Urol. 2021.08; ( PubMed, DOI )

  45. Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Sosan Azizi, Kees Hendricksen, Alberto Martini, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Alessandro Tafuri, Alessandro Antonelli, Maria Angela Cerruto, Morgan Rouprêt, Alexandra Masson-Lecomte, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat, Francesco Soria, Giancarlo Marra, Paolo Gontero, Roberto Contieri, Rodolfo Hurle, Anne Sophie Valiquette, M Carmen Mir, Stefania Zamboni, Claudio Simeone, Tobias Klatte, Jeremy Yuen-Chun Teoh, Soichiro Yoshida, Yasuhisa Fujii, Roberto Carando, Gerald B Schulz, Livio Mordasini, Agostino Mattei, Marco Moschini, . Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. Eur Urol Focus. 2021.08; ( PubMed, DOI )

  46. Shimpei Yamamoto, Soichiro Yoshida, Chikako Ishii, Taro Takahara, Yuki Arita, Hiroshi Fukushima, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. J Magn Reson Imaging. 2021.08; 54 (2): 401-408. ( PubMed, DOI )

  47. Sunil H Patel, Ithaar H Derweesh, Kazutaka Saito, Dattatraya Patil, Margaret F Meagher, Ahmet Bindayi, Ahmed Eldefrawy, Devin N Patel, Ryan Nasseri, Yosuke Yasuda, Yasuhisa Fujii, Viraj A Master. Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC). Clin Genitourin Cancer. 2021.08; 19 (4): e206-e215. ( PubMed, DOI )

  48. Masaki Kobayashi, Junichiro Ishioka, Yoh Matsuoka, Yuichi Fukuda, Yusuke Kohno, Keizo Kawano, Shinji Morimoto, Rie Muta, Motohiro Fujiwara, Naoko Kawamura, Tetsuo Okuno, Soichiro Yoshida, Minato Yokoyama, Rumi Suda, Ryota Saiki, Kenji Suzuki, Itsuo Kumazawa, Yasuhisa Fujii. Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray. BMC Urol. 2021.08; 21 (1): 102. ( PubMed, DOI )

  49. Soichiro Yoshida, Yoh Matsuoka, Kazuma Toda, Sho Uehara, Hajime Tanaka, Minato Yokoyama, Kazutaka Saito, Ryoichi Yoshimura, Yasuhisa Fujii. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU Case Rep. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

  50. Kazutaka Saito, Yoh Matsuoka, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Kazunori Kihara, Yasuhisa Fujii. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer. Brachytherapy. 2021.07; 20 (4): 842-848. ( PubMed, DOI )

  51. Soichiro Yoshida, Yasuhisa Fujii. Editorial Comment to Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy. Int J Urol. 2021.07; 28 (7): 756. ( PubMed, DOI )

  52. Koichiro Kimura, Soichiro Yoshida, Junichi Tsuchiya, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Ukihide Tateishi, Yasuhisa Fujii. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. Eur Radiol. 2021.06; ( PubMed, DOI )

  53. Soichiro Yoshida, Taro Takahara, Yuki Arita, Kazuma Toda, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy. Int Urol Nephrol. 2021.06; 53 (6): 1119-1125. ( PubMed, DOI )

  54. Soichiro Yoshida, Taro Takahara, Yuki Arita, Shinjiro Sakaino, Kazuhiro Katahira, Yasuhisa Fujii. Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond. Int J Urol. 2021.05; 28 (5): 502-513. ( PubMed, DOI )

  55. Hajime Tanaka, Yasuhisa Fujii. Editorial Comment. J Urol. 2021.05; 205 (5): 1319-1320. ( PubMed, DOI )

  56. Yuki Arita, Soichiro Yoshida, Yuma Waseda, Taro Takahara, Chikako Ishii, Ryo Ueda, Thomas C Kwee, Kei Miyahira, Ryota Ishii, Shigeo Okuda, Masahiro Jinzaki, Yasuhisa Fujii. Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer. Eur J Radiol. 2021.04; 137 109581. ( PubMed, DOI )

  57. Toshiki Kijima, Hiroshi Fukushima, Shota Kusuhara, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Yasuyuki Sakai, Kazutaka Saito, Nobuaki Matsubara, Takeshi Yuasa, Hitoshi Masuda, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clin Genitourin Cancer. 2021.04; 19 (3): 208-216.e1. ( PubMed, DOI )

  58. Brittney H Cotta, Margaret F Meagher, Dattatraya Patil, Kazutaka Saito, Sunil H Patel, Devin N Patel, Nathan Miller, Raksha Dutt, Cathrine Keiner, Aaron W Bradshaw, Fang Wan, Ahmed Eldefrawy, Yosuke Yasuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC). BJU Int. 2021.04; 127 (3): 311-317. ( PubMed, DOI )

  59. Soichiro Yoshida, Yasuhisa Fujii. Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer. IJU Case Rep. 2021.03; 4 (2): 73-74. ( PubMed, DOI )

  60. Toshiki Kijima, Hina Yamamoto, Kazutaka Saito, Shota Kusuhara, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Yasuyuki Sakai, Nobuaki Matsubara, Takeshi Yuasa, Hitoshi Masuda, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer Immunol Immunother. 2021.03; 70 (3): 657-665. ( PubMed, DOI )

  61. Shohei Fukuda, Kazutaka Saito, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Yukio Kageyama, Yasuhisa Fujii. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. J Immunother Cancer. 2021.02; 9 (2): ( PubMed, DOI )

  62. Takahiko Soma, Minato Yokoyama, Yusuke Uchida, Susumu Kirimura, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Yasuhisa Fujii. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. Int Cancer Conf J. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

  63. Yosuke Yasuda, Kazutaka Saito, Hajime Tanaka, Sho Uehara, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique. Int J Urol. 2021.01; 28 (3): 302-307. ( PubMed, DOI )

  64. Soichiro Yoshida, Hisashi Matsushima, Yasuhisa Fujii. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity. World J Urol. 2021.01; ( PubMed, DOI )

  65. Hiroshi Fukushima, Soichiro Yoshida, Toshiki Kijima, Yuki Nakamura, Shohei Fukuda, Sho Uehara, Yosuke Yasuda, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma. Int J Mol Sci. 2021.01; 22 (2): ( PubMed, DOI )

  66. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. . Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique Int J Urol.. 2020.12;

  67. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patientsOutcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients Feasibility of a clampless and sutureless technique Int J Urol. 2020 Dec 9. doi: 10.1111/iju.14452. 2020.12;

  68. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation Low Urin Tract Symptoms. 2020.12;

  69. Yoshida S, Takahara T, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. . Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? Int J Urol. 2020 Nov 2. doi: 10.1111/iju.14421.. 2020.11;

  70. Yamamoto S, Kageyama Y, Fujii Y, Aizawa T, Urakami S, Fukui I. Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer Anticancer Res. 2020.09;

  71. Suto EG, Mabuchi Y, Toyota S, Taguchi M, Naraoka Y, Itakura N, Matsuoka Y, Fujii Y, Miyasaka N, Akazawa C. Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells Sci Rep. 2020.09;

  72. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab Cancer Immunol Immunother. 2020.09;

  73. Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, Ohyama C, Ogawa O, Kikuchi E, Kitamura H, Shinohara N, Takahashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishiyama H, Habuchi T, Hinotsu S, Fujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Matsuyama H. Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision Int J Urol. 2020.09;

  74. Yoh Matsuoka, Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Kazutaka Saito, Yasuhisa Fujii. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020.09; 27 (9): 760-766. ( PubMed, DOI )

  75. Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy Clin Genitourin Cancer. 2020.08;

  76. Izumi K, Saito K, Nakayama T, Fukuda S, Fukushima H, Uehara S, Koga F, Yonese J, Kageyama Y, Fujii Y. Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma Int J Urol. 2020.08;

  77. Cotta BH, Meagher MF, Patil D, Saito K, Patel SH, Patel DN, Miller N, Dutt R, Keiner C, Bradshaw AW, Wan F, Eldefrawy A, Yasuda Y, Fujii Y, Master V, Derweesh IH. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC) BJU Int. 2020.08;

  78. Keita Izumi, Kazutaka Saito, Takayuki Nakayama, Shohei Fukuda, Hiroshi Fukushima, Sho Uehara, Fumitaka Koga, Junji Yonese, Yukio Kageyama, Yasuhisa Fujii. Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma. Int J Urol. 2020.08; 27 (8): 657-662. ( PubMed, DOI )

  79. Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review Clin Genitourin Cancer. 2020.07;

  80. Masaki Kobayashi, Minato Yokoyama, Masaharu Inoue, Yasuhisa Fujii. Undifferentiated prostate cancer treated with docetaxel. IJU Case Rep. 2020.07; 3 (4): 125-127. ( PubMed, DOI )

  81. Hiroaki Matsumoto, Koji Shiraishi, Haruhito Azuma, Keiji Inoue, Hirotsugu Uemura, Masatoshi Eto, Chikara Ohyama, Osamu Ogawa, Eiji Kikuchi, Hiroshi Kitamura, Nobuo Shinohara, Satoru Takahashi, Toyonori Tsuzuki, Masayuki Nakagawa, Yoshifumi Narumi, Hiroyuki Nishiyama, Tomonori Habuchi, Shiro Hinotsu, Yasuhisa Fujii, Kiyohide Fujimoto, Hiroyuki Fujimoto, Takashi Mizowaki, Hideyasu Matsuyama. Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision. Int J Urol. 2020.06; 27 (9): 702-709. ( PubMed, DOI )

  82. Shunya Matsumoto, Toshiki Kijima, Yoh Matsuoka, Masahide Yamamoto, Yasuhisa Fujii. A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab. Eur J Cancer 131(2020) 104-107. doi: 10.1016/j.ejca.2020.02.043. 2020.05;

  83. Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, Ohyama C, Ogawa O, Kikuchi E, Kitamura H, Shinohara N, Takahashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishiyama H, Habuchi T, Hinotsu S, Fujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Matsuyama H. Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper Int J Urol. 2020.05;

  84. Ishii A, Yokoyama M, Tsuji H, Fujii Y, Tamaoka A. Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis eNeurologicalSci. 2020.04;

  85. Waseda Y, Kobayashi S, Kanda E, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model Clin Genitourin Cancer. 2020.04;

  86. Kijima T, Ito M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Treatment-induced changes in levels of brain natriuretic peptide in prostate cancer patients receiving gonadotropin-releasing hormone antagonists or agonists Int J Urol. 2020.04;

  87. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

  88. Tanaka H, Kijima T, Fujii Y. Bladder preservation therapy in muscle-invasive bladder cancer: Current evidence and future perspectives AME Medical Journal. 2020.02;

  89. Yoshihiko Tomita, Tsunenori Kondo, Go Kimura, Takamitsu Inoue, Yoshiaki Wakumoto, Masahiro Yao, Takayuki Sugiyama, Mototsugu Oya, Yasuhisa Fujii, Wataru Obara, Robert J Motzer, Hirotsugu Uemura. Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up. Jpn. J. Clin. Oncol.. 2020.01; 50 (1): 12-19. ( PubMed, DOI )

  90. Tomita Y, Kondo T, Kimura G, Inoue T, Wakumoto Y, Yao M, Sugiyama T, Oya M, Fujii Y, Obara W, Motzer RJ, Uemura H. Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up Jpn J Clin Oncol. 2020.01;

  91. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y. . Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. Int J Urol. 2020; 27: 634-635. doi: 10.1111/iju.14249.. 2020;

  92. Kobayashi M, Yokoyama M, Inoue M, Fujii Y. Undifferentiated prostate cancer treated with docetaxel IJU Case Reports. 2020;

  93. Ishii A, Yokoyama M, Tsuji H, Fujii Y, Tamaoka A. Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis eNeurologicalSci. 2020;

  94. Fukushima H, Fujii Y. Editorial Comment to Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guerin? Int J Urol. 2020;

  95. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC) Clin Genitourin Cancer. 2020;

  96. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

  97. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications Clin Genitourin Cancer. 2020;

  98. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

  99. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

  100. Tanaka H, Fujii Y. Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence Int J Urol. 2020. doi: 10.1111/iju.14419. 2020;

  101. Tanaka H, Fujii Y. Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns following laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort Int J Urol. 2020. doi: 10.1111/iju.14194. 2020;

  102. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

  103. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

  104. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

  105. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol. 2020 Jul;27(7):599-604. doi: 10.1111/iju.14251.. 2020;

  106. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. Int J Urol. 2020; 27: 471-472. doi: 10.1111/iju.14204.. 2020;

  107. Toshiki Kijima, Hajime Tanaka, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019.12;

  108. SoichiroYoshida, TaroTakahara, Chikako Ishii, Yuki Arita, Yuma Waseda, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer 2019.12;

  109. HiroshiFukushima, KazutakaSaito, YosukeYasuda, HajimeTanaka, DattatrayaPatil, Brittney H.Cotta, Sunil H.Patel, Viraj A.Master, Ithaar H.Derweesh, YasuhisaFujii. Female sex predicts favorable prognosis in non-metastatic clear cell renal cell carcinoma patients undergoing curative surgery: results from the International Marker Consortium for Renal Cancer (INMARC) 2019.11;

  110. Yuki Arita, Taro Takahara, Soichiro Yoshida, Thomas C Kwee, Shugo Yajima, Chikako Ishii, Ryota Ishii, Shigeo Okuda, Masahiro Jinzaki, Yasuhisa Fujii. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. Invest Radiol. 2019.10; 54 (10): 638-644. ( PubMed, DOI )

  111. Soichiro Yoshida, Taro Takahara, Yuki Arita, Chikako Ishii, Yusuke Uchida, Keiko Nakagawa, Kazuma Toda, Tsuyoshi Sakamoto, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Ryoichi Yoshimura, Yasuhisa Fujii. Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor. Int. J. Radiat. Oncol. Biol. Phys.. 2019.10; 105 (2): 376-381. ( PubMed, DOI )

  112. Masahiro Toide, Minato Yokoyama, Motohiro Fujiwara, Toshiki Kijima, Kazutaka Saito, Yasuhisa Fujii. Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy. Int. J. Urol.. 2019.10; 26 (10): 1010-1012. ( PubMed, DOI )

  113. Hiroshi Fukushima, Yasuhisa Fujii. Editorial Comment to Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guérin? Int. J. Urol.. 2019.10; ( PubMed, DOI )

  114. Yuma Waseda, Shuichiro Kobayashi, Eiichiro Kanda, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model. Clin Genitourin Cancer. 2019.10; ( PubMed, DOI )

  115. Soichiro Yoshida, Yasuhisa Fujii. Editorial Comment to Virtual reality of three-dimensional surgical field for surgical planning and intraoperative management. Int. J. Urol.. 2019.09; 26 (9): 944. ( PubMed, DOI )

  116. Toshiki Kijima, Hajime Tanaka, Fumitaka Koga, Hitoshi Masuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int.. 2019.08; 124 (2): 242-250. ( PubMed, DOI )

  117. Masaki Kobayashi, Hajime Tanaka, Ukihide Tateishi, Noboru Numao, Junji Yonese, Masaya Ito, Fumitaka Koga, Hiroshi Fukushima, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int J Urol. 2019.08; 26 (8): 820-826. ( PubMed, DOI )

  118. Shugo Yajima, Soichiro Yoshida, Taro Takahara, Yuki Arita, Hiroshi Tanaka, Yuma Waseda, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression. Eur Radiol. 2019.07; 29 (7): 3881-3888. ( PubMed, DOI )

  119. Atsushi Mizokami, Go Kimura, Yasuhisa Fujii, Shiro Hinotsu, Kouji Izumi. Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial. Int. J. Clin. Oncol.. 2019.07; 24 (12): 1629-1631. ( PubMed, DOI )

  120. Soichiro Yoshida, Takeshi Maeda, Minato Yokoyama, Masahiro Toide, Kazutaka Saito, Yasuhisa Fujii. Application of eye tracking as a user interface for urological surgery. Int. J. Urol.. 2019.06; 26 (6): 680-681. ( PubMed, DOI )

  121. Soichiro Yoshida, Maki Sugimoto, Shohei Fukuda, Naoji Taniguchi, Kazutaka Saito, Yasuhisa Fujii. Mixed reality computed tomography-based surgical planning for partial nephrectomy using a head-mounted holographic computer. Int. J. Urol.. 2019.06; 26 (6): 681-682. ( PubMed, DOI )

  122. Toshiki Kijima, Thomas Prince, Len Neckers, Fumitaka Koga, Yasuhisa Fujii. Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progress. Expert Opin. Ther. Targets. 2019.05; 23 (5): 369-377. ( PubMed, DOI )

  123. Hiroshi Fukushima, Yasuhisa Fujii, Fumitaka Koga. Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma. Int J Mol Sci. 2019.02; 20 (3): ( PubMed, DOI )

  124. Waseda Yuma, Saito Kazutaka, Ishikawa Yudai, Kawano Keizo, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Morimoto Shinji, Kihara Kazunori, Fujii Yasuhisa. Predictive ability of renal cortex enhancement in dynamic computed tomography for residual renal function after nephroureterectomy: Comparison with 99m Tc-diethylenetriaminopentacetic acid renography and validation study. International Journal of Urology. 2019.02; 26 (2): 266-272. ( ichushi )

  125. Hiroshi Watanabe, Hajime Tanaka, Yasuhisa Fujii, Makoto Kodama, Takumi Akashi, Tomoyuki Fujioka, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi. A case of immunoglobulin G4-related inflammatory pseudotumor mimicking renal cell carcinoma. Abdom Radiol (NY). 2019.01; ( PubMed, DOI )

  126. Saori Araki, Toshiki Kijima, Yuma Waseda, Yoshinobu Komai, Yasukazu Nakanishi, Sho Uehara, Yosuke Yasuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yujiro Nakano, Takanobu Yoshimoto, Tokujiro Uchida, Yasuhisa Fujii. Incidence and predictive factors of hypoglycemia after pheochromocytoma resection. Int. J. Urol.. 2018.11; ( PubMed, DOI )

  127. Soma Takahiko, Ishioka Junichiro, Tanaka Hajime, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. International Journal of Urology. 2018.11; 25 (11): 978-979. ( ichushi )

  128. Kawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urologia internationalis. 2018.10; 1-6. ( PubMed, DOI )

  129. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  130. Waseda Y, Saito K, Ishikawa Y, Kawano K, Yokoyama M, Ishioka J, Matsuoka Y, Morimoto S, Kihara K, Fujii Y. Predictive ability of renal cortex enhancement in dynamic computed tomography for residual renal function after nephroureterectomy: Comparison with <sup>99m</sup> Tc-diethylenetriaminopentacetic acid renography and validation study. International journal of urology : official journal of the Japanese Urological Association. 2018.10; ( PubMed, DOI )

  131. Nakano Yujiro, Yoshimoto Takanobu, Fukuda Tatsuya, Murakami Masanori, Bouchi Ryotaro, Minami Isao, Hashimoto Koshi, Fujii Yasuhisa, Kihara Kazunori, Ogawa Yoshihiro. Effect of Eplerenone on the Glomerular Filtration Rate(GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy(和訳中) Internal Medicine. 2018.09; 57 (17): 2459-2466. ( ichushi )

  132. Kawamura N, Yokoyama M, Tanaka H, Nakayama T, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. International journal of urology . 2018.09; ( PubMed, DOI )

  133. Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. Int. J. Urol.. 2018.08; ( PubMed, DOI )

  134. Nakayama T, Saito K, Kumagai J, Nakajima Y, Kijima T, Yoshida S, Kihara K, Fujii Y. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Clinical genitourinary cancer. 2018.08; ( PubMed, DOI )

  135. Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int. J. Urol.. 2018.06; 25 (6): 554-560. ( PubMed, DOI )

  136. Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed, DOI )

  137. Moriyama Shingo, Yoshida Soichiro, Tanaka Hajime, Tanaka Hiroshi, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma(和訳中) International Journal of Urology. 2018.06; 25 (6): 554-560. ( ichushi )

  138. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Noboru Numao, Tomo Kimura, Kosei Kudo, Itsuo Kumazawa, Yasuhisa Fujii. Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm. BJU Int.. 2018.05; ( PubMed, DOI )

  139. Kasumi Kaneko, Soichiro Yoshida, Taro Takahara, Shugo Yajima, Tsuyoshi Sakamoto, Thomas Kwee, Yuki Arita, Minato Yokoyama, and others. MP20-18 SEMI-AUTOMATIC SEGMENTATION ANALYSIS OF DIFFUSION-WEIGHTED MRI AS AN IMAGING BIOMARKER FOR HISTOLOGICAL GRADE OF BLADDER CANCER the joural of UROLGY. 2018.04;

  140. Toshiki Kijima, Thomas Prince, Katsuo Mori, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, and others. MP64-14 TARGETING HEAT SHOCK FACTOR 1 SENSITIZES CASTRATION-RESISTANT PROSTATE CANCER CELLS TO HSP90 INHIBITION IN PART BY DESTABILIZING ANDROGEN RECEPTOR SPLICE VARIANTS the joural of UROLGY. 2018.04;

  141. Yosuke Yasuda, Kazutaka Saito, Takahiko Soma, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, and others. PD07-05 THE OUTCOME OF GASLESS LAPAROSCOPIC SINGLE-PORT CLAMPLESS SUTURELESS PARTIAL NEPHRECTOMY USING THREE-DIMENSIONAL HEAD-MOUNTED DISPLAY the joural of UROLGY. 2018.04;

  142. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Yuma Waseda, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, and others. MP20-09 MRI-BASED RISK ASSESSMENT FOR POSTOPERATIVE BIOCHEMICAL RECURRENCE USING THE PROSTATE IMAGING REPORTING AND DATA SYSTEM (PI-RADS) SCORES AND CAPSULAR CONTACT LENGTH the joural of UROLGY. 2018.04;

  143. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, and others. MP20-10 DEEP LEARNING WITH A CONVOLUTIONAL NEURAL NETWORK ALGORITHM FOR FULLY AUTOMATED DETECTION OF PROSTATE CANCER USING PRE-BIOPSY MRI the joural of UROLGY. 2018.04;

  144. Yujiro Nakano, Takanobu Yoshimoto, Tatsuya Fukuda, Masanori Murakami, Ryotaro Bouchi, Isao Minami, Koshi Hashimoto, Yasuhisa Fujii, Kazunori Kihara, Yoshihiro Ogawa. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy. Intern. Med.. 2018.04; ( PubMed, DOI )

  145. Takuya Adachi, Minato Yokoyama, Yasuhisa Fujii, Yuko Kinowaki, Susumu Kirimura, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi. Neuroblastic tumors in young adults as a sequela of malignant neuroblastoma: report of two cases. Abdom Radiol (NY). 2018.04; ( PubMed, DOI )

  146. Yosuke Yasuda, Kazutaka Saito, Takahiko Soma, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii . PD07-05 THE OUTCOME OF GASLESS LAPAROSCOPIC SINGLE-PORT CLAMPLESS SUTURELESS PARTIAL NEPHRECTOMY USING THREE-DIMENSIONAL HEAD-MOUNTED DISPLAY 2018.04;

  147. shugo yajima, Soichiro Yoshida、 Taro Takahara Minato Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii . MP08-03 ABSENCE OF INCHWORM SIGN ON DWI: A PREDICTIVE MARKER FOR PROGRESSION IN PT1 BLADDER CANCER the joural of UROLGY. 2018.04;

  148. Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Sho Uehara, Yousuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. MP36-08 A CONVOLUTIONAL NEURAL NETWORKS ALGORITHM FOR DIFFERENTIAL DIAGNOSIS OF FAT-POOR ANGIOMYOLIPOMA AND RENAL CELL CARCINOMA IN ENHANCED CT AND T2-WEIGHTED MAGNETIC RESONANCE IMAGING the joural of UROLGY. 2018.04;

  149. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Yuma Waseda, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, and others. MP20-09 MRI-BASED RISK ASSESSMENT FOR POSTOPERATIVE BIOCHEMICAL RECURRENCE USING THE PROSTATE IMAGING REPORTING AND DATA SYSTEM (PI-RADS) SCORES AND CAPSULAR CONTACT LENGTH 2018.04;

  150. Kenji Tanabe, Kazutaka Saito, Kazuaki Nakagomi, Chizuru Arisawa, Tetsuro Tsukamoto, Tetsuo Okuno, Katsushi Nagahama, Akira Noro, and others. MP36-05 CHANGES IN PATTERN OF RECURRENCE OVER TIME AFTER RADICAL NEPHRECTOMY IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA the joural of UROLGY. 2018.04;

  151. Minato Yokoyama, Naoko Kawamura, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, and others. MP42-05 ACUTE KIDNEY INJURY AND INTERMEDIATE-TERM RENAL FUNCTION AFTER CLAMPLESS PARTIAL NEPHRECTOMY the joural of UROLGY. 2018.04;

  152. Yoh Matsuoka, Hiroshi Tanaka, Tomo Kimura, Yuma Waseda, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, and others. PD47-11 THE ROLE OF MRI-TARGETED BIOPSY IN PREDICTION OF ADVERSE PATHOLOGICAL AND ONCOLOGICAL OUTCOME AFTER RADICAL PROSTATECTOMY the joural of UROLGY. 2018.04;

  153. Yosuke Yasuda, Kazutaka Saito, Takahiko Soma, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, and others. PD07-05 THE OUTCOME OF GASLESS LAPAROSCOPIC SINGLE-PORT CLAMPLESS SUTURELESS PARTIAL NEPHRECTOMY USING THREE-DIMENSIONAL HEAD-MOUNTED DISPLAY the joural of UROLGY. 2018.04;

  154. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Yuma Waseda, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, and others. MP20-09 MRI-BASED RISK ASSESSMENT FOR POSTOPERATIVE BIOCHEMICAL RECURRENCE USING THE PROSTATE IMAGING REPORTING AND DATA SYSTEM (PI-RADS) SCORES AND CAPSULAR CONTACT LENGTH the joural of UROLGY. 2018.04;

  155. Matsuoka Yoh, Tanaka Hiroshi, Kimura Tomo, Waseda Yuma, Uehara Sho, Yasuda Yosuke, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Clinical significance of MRI-targeted biopsy for the risk stratification of oncological outcome after radical prostatectomy(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 AOP-070. ( ichushi )

  156. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 IS-75. ( ichushi )

  157. Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Novel therapy targeting androgen receptor splice variants by inhibiting heat shock factor 1(HSF1) for the treatment of castration-resistant prostate cancer(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 AOP-065. ( ichushi )

  158. 齋藤 一隆, 松岡 陽, 吉田 宗一郎, 藤井 靖久. MRI/US fusion biopsyの現在と未来 MRI-超音波弾性融合画像生検の前立腺部分治療への適用 日本泌尿器科学会総会. 2018.04; 106回 SY11-1. ( ichushi )

  159. Uehara Sho, Yoshida Soichiro, Matsuoka Yoh, Yasuda Yosuke, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Head-mounted display assisted MRI-US elastic fusion prostate biopsy system(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 AVP-06. ( ichushi )

  160. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 IS-68. ( ichushi )

  161. Fujii Yasuhisa. Prediction models for progression of non-muscle-invasive bladder cancer: A review(和訳中) International Journal of Urology. 2018.03; 25 (3): 212-218. ( ichushi )

  162. Umakoshi Hironobu, Tsuiki Mika, Takeda Yoshiyu, Kurihara Isao, Itoh Hiroshi, Katabami Takuyuki, Ichijo Takamasa, Wada Norio, Yoshimoto Takanobu, Ogawa Yoshihiro, Kawashima Junji, Sone Masakatsu, Inagaki Nobuya, Takahashi Katsutoshi, Watanabe Minemori, Matsuda Yuichi, Kobayashi Hiroki, Shibata Hirotaka, Kamemura Kohei, Otsuki Michio, Fujii Yuichi, Yamamto Koichi, Ogo Atsushi, Yanase Toshihiko, Suzuki Tomoko, Naruse Mitsuhide. Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2018.03; 103 (3): 900-908. ( DOI )

  163. Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol. Int.. 2018.01; 100 (1): 85-91. ( PubMed, DOI )

  164. Yosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, Sho Uehara, Naoko Kawamura, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Shinya Yamamoto, Tetsuo Okuno, Junji Yonese, Kazunori Kihara, Yasuhisa Fujii. Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int. J. Clin. Oncol.. 2017.12; 22 (6): 1081-1086. ( PubMed, DOI )

  165. Yasuhisa Fujii. Prediction models for progression of non-muscle-invasive bladder cancer: A review. Int. J. Urol.. 2017.12; ( PubMed, DOI )

  166. Yasuda Yosuke, Saito Kazutaka, Yuasa Takeshi, Uehara Sho, Kawamura Naoko, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Yamamoto Shinya, Okuno Tetsuo, Yonese Junji, Kihara Kazunori, Fujii Yasuhisa. Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors(和訳中) International Journal of Clinical Oncology. 2017.12; 22 (6): 1081-1086. ( ichushi )

  167. Masanori Murakami, Takanobu Yoshimoto, Kazuhiko Nakabayashi, Yujiro Nakano, Takahiro Fukaishi, Kyoichiro Tsuchiya, Isao Minami, Ryotaro Bouchi, Kohji Okamura, Yasuhisa Fujii, Koshi Hashimoto, Ken-Ichiro Hata, Kazunori Kihara, Yoshihiro Ogawa. Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas. Endocr. Relat. Cancer. 2017.10; 24 (10): 531-541. ( PubMed, DOI )

  168. Kazutaka Saito, Yasuhisa Fujii. Antitumor Activity and Safety of Enzalutamide After Abiraterone Acetate: Seeking the Optimal Treatment Sequence for Castration-resistant Prostate Cancer Patients. Eur. Urol.. 2017.10; ( PubMed, DOI )

  169. Hiroshi Fukushima, Madoka Kataoka, Yasukazu Nakanishi, Kazumasa Sakamoto, Kosuke Takemura, Hiroaki Suzuki, Masaya Ito, Ken-Ichi Tobisu, Yasuhisa Fujii, Fumitaka Koga. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy. Urol. Oncol.. 2017.10; ( PubMed, DOI )

  170. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR Am J Roentgenol. 2017.08; 209 (2): W76-W84. ( PubMed, DOI )

  171. Soichiro Yoshida, Tsuneo Fukuyo, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery. Int. J. Urol.. 2017.08; 24 (8): 639-640. ( PubMed, DOI )

  172. Yuma Waseda, Soichiro Yoshida, Taro Takahara, Thomas Christian Kwee, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer. J Magn Reson Imaging. 2017.08; 46 (2): 490-496. ( PubMed, DOI )

  173. Yoshida Soichiro, Fukuyo Tsuneo, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 単孔式腹腔鏡下手術における手-目協調の改善のためのリアルタイム三次元画像の角度調整(Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery) International Journal of Urology. 2017.08; 24 (8): 639-640. ( ichushi )

  174. Hajime Tanaka, Yasuhisa Fujii, Hiroshi Tanaka, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Sho Uehara, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Junji Yonese, Kazunori Kihara. Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int. J. Urol.. 2017.07; 24 (7): 511-517. ( PubMed, DOI )

  175. Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clin Imaging. 2017.07; 44 121-126. ( PubMed, DOI )

  176. Tanaka Hajime, Fujii Yasuhisa, Tanaka Hiroshi, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Uehara Sho, Numao Noboru, Yuasa Takeshi, Yamamoto Shinya, Masuda Hitoshi, Yonese Junji, Kihara Kazunori. 小径腎腫瘍中の脂肪成分の少ない腎血管筋脂肪腫診断のためのCTおよびMRIを用いたステップワイズアルゴリズム 開発および外的妥当性(Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation) International Journal of Urology. 2017.07; 24 (7): 511-517. ( ichushi )

  177. Hajime Tanaka, Yasuhisa Fujii, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara. Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques. Int. J. Urol.. 2017.06; 24 (6): 472-473. ( PubMed, DOI )

  178. Soichiro Yoshida, Taro Takahara, Thomas C Kwee, Yuma Waseda, Shuichiro Kobayashi, Yasuhisa Fujii. DWI as an Imaging Biomarker for Bladder Cancer. AJR Am J Roentgenol. 2017.06; 208 (6): 1218-1228. ( PubMed, DOI )

  179. Tanaka Hajime, Fujii Yasuhisa, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. 無阻血・無縫合法による低侵襲性腎部分切除術後のCTにおける仮性腎動脈瘤の非描出(Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques) International Journal of Urology. 2017.06; 24 (6): 472-473. ( ichushi )

  180. Tanaka Hajime, Yoshida Soichiro, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 免疫組織化学に基づいた分子的サブタイプ判定による筋層浸潤性膀胱癌における化学放射線療法に対する感受性の予測(Immunohistochemistry-based molecular subtypes predict therapeutic sensitivity of chemoradiotherapy in muscle-invasive bladder cancer) 日本泌尿器科学会総会. 2017.04; 105回 AOP11-07. ( ichushi )

  181. Yokoyama Minato, Koga Fumitaka, Otsuka Yukihiro, Tsukamoto Tetsuro, Okuno Tetsuo, Nagahama Katsushi, Kageyaam Yukio, Noro Akira, Tsujii Toshihiko, Morimoto Shinji, Kitahara Satoshi, Kihara Kazunori, Fujii Yasuhisa. 根治的腎切除術後の残存腎機能低下に関する術前推定糸球体濾過率低下と高血圧の意義(Significance of decreased preoperative estimated glomerular filtration rate and hypertension on decline in remaining kidney function after radical nephrectomy) 日本泌尿器科学会総会. 2017.04; 105回 JUA-Oral09. ( ichushi )

  182. Matsuoka Yoh, Tanaka Hiroshi, Kimura Tomo, Ito Masaya, Inoue Masaharu, Kijima Toshiki, Yoshida Soichiro, Kawamura Naoko, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 根治的前立腺切除術後の生化学的再発に関するMRI標的化生検と系統的生検の予測能の比較(MRI-targeted biopsy vs. systematic biopsy in prediction of biochemical recurrence after radical prostatectomy) 日本泌尿器科学会総会. 2017.04; 105回 AOP06-04. ( ichushi )

  183. Ishioka Junichiro, Matsuoka Yoh, Itoh Masaya, Inoue Masaharu, Kijima Toshiki, Yoshida Sohichiro, Yokoyama Minato, Saitoh Kazutaka, Kihara Kazunori, Fujii Yasuhisa, Tanaka Hiroshi, Kimura Tomo. 生検前MRIのためのdeep learning architectureによる前立腺癌コンピューター支援診断法(Computer-aided diagnosis of prostate cancer with deep learning architecture for pre-biopsy MRI) 日本泌尿器科学会総会. 2017.04; 105回 AOP05-04. ( ichushi )

  184. Inoue Masaharu, Fujii Yasuhisa, Ito Masaya, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. 部分腎切除術後の高血圧進行とその危険因子(Progression of hypertension after partial nephrectomy and its risk factors) 日本泌尿器科学会総会. 2017.04; 105回 AOP02-01. ( ichushi )

  185. Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urol. Int.. 2017.03; 98 (3): 298-303. ( PubMed, DOI )

  186. Mutsushi Yamasaki, Takeshi Yuasa, Sho Uehara, Yasuhisa Fujii, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui, Junji Yonese. Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab. Int. J. Clin. Oncol.. 2016.12; 21 (6): 1191-1195. ( PubMed, DOI )

  187. Masanori Murakami, Takanobu Yoshimoto, Yujiro Nakano, Kyoichiro Tsuchiya, Isao Minami, Ryotaro Bouchi, Yasuhisa Fujii, Kazuhiko Nakabayashi, Koshi Hashimoto, Ken-Ichiro Hata, Kazunori Kihara, Yoshihiro Ogawa. Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutation. Biochem. Biophys. Res. Commun.. 2016.08; 476 (4): 614-619. ( PubMed, DOI )

  188. Toshihiro Kanda, Syohei Fukuda, Naotaka Fukui, Yu Ohkubo, Tomoko Kazumoto, Yoshihiro Saito, Ayataka Ishikawa, Masafumi Kurosumi, Yukio Kageyama, Yasuhisa Fujii, Kazunori Kihara. Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer. Int. J. Clin. Oncol.. 2016.08; 21 (4): 764-772. ( PubMed, DOI )

  189. Naoko Kawamura, Minato Yokoyama, Yasuhisa Fujii, Junichiro Ishioka, Noboru Numao, Yoh Matsuoka, Kazutaka Saito, Chizuru Arisawa, Tetsuo Okuno, Akira Noro, Shinji Morimoto, Kazunori Kihara. Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter longitudinal study. Int. J. Urol.. 2016.03; 23 (3): 219-223. ( PubMed, DOI )

  190. Takayuki Nakayama, Noboru Numao, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. A novel interactive educational system in the operating room--the IE system. BMC Med Educ. 2016.02; 16 44. ( PubMed, DOI )

  191. Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Yasuyuki Sakai, Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Mitsuru Koizumi, Atsushi Kohno, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urol. Int.. 2016.01; 96 (1): 65-72. ( PubMed, DOI )

  192. Takeshi Yuasa, Naoko Inoshita, Hajime Tanaka, Shinji Urakami, Shinya Yamamoto, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Yuichi Ishikawa, Junji Yonese. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1198-1202. ( PubMed, DOI )

  193. Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Mizuaki Sakura, Hajime Tanaka, Tatsuro Hayashi, Sho Uehara, Yasushi Inoue, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Junji Yonese. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1171-1178. ( PubMed, DOI )

  194. Yasuhisa Fujii. Editorial Comment from Dr Fujii to Early unclamping might reduce the risk of renal artery pseudoaneurysm after robot-assisted laparoscopic partial nephrectomy. Int. J. Urol.. 2015.12; 22 (12): 1103. ( PubMed, DOI )

  195. Masanori Murakami, Takanobu Yoshimoto, Isao Minami, Ryotaro Bouchi, Kyoichiro Tsuchiya, Koshi Hashimoto, Hajime Izumiyama, Yasuhisa Fujii, Takashi Endo, Takumi Akashi, Koshiro Nishimoto, Kuniaki Mukai, Kazunori Kihara, Yoshihiro Ogawa. A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma. Endocr. Pathol.. 2015.10; ( PubMed, DOI )

  196. Soichiro Yoshida, Asami Sasaki, Chikage Sato, Mutsuko Yamazaki, Junya Takayasu, Naofumi Tanaka, Norie Okabayashi, Hiromi Hirano, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. A Novel Approach to Surgical Instructions for Scrub Nurses by Using See-Through-Type Head-Mounted Display. Comput Inform Nurs. 2015.08; 33 (8): 335-338. ( PubMed, DOI )

  197. Masanori Murakami, Takanobu Yoshimoto, Kazuhiko Nakabayashi, Kyoichiro Tsuchiya, Isao Minami, Ryotaro Bouchi, Hajime Izumiyama, Yasuhisa Fujii, Kosei Abe, Chiharu Tayama, Koshi Hashimoto, Takayoshi Suganami, Ken-ichiro Hata, Kazunori Kihara, Yoshihiro Ogawa. Integration of transcriptome and methylome analysis of aldosterone-producing adenomas. Eur. J. Endocrinol.. 2015.08; 173 (2): 185-195. ( PubMed, DOI )

  198. Kenji Tanabe, Soichiro Yoshida, Fumitaka Koga, Masaharu Inoue, Shuichiro Kobayashi, Junichiro Ishioka, Tomoki Tamura, Emiko Sugawara, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, Kazunori Kihara. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol. Clin Genitourin Cancer. 2015.08; 13 (4): e243-e251. ( PubMed, DOI )

  199. Masaharu Inoue, Yasuhisa Fujii, Minato Yokoyama, Kazutaka Saito, Noboru Numao, Kazunori Kihara. Progression of hypertension after partial nephrectomy in patients with renal tumors: A preliminary report. Int. J. Urol.. 2015.08; 22 (8): 797-798. ( PubMed, DOI )

  200. Soichiro Yoshida, Kazunori Kihara, Tsuneo Fukuyo, Junichiro Ishioka, Kazutaka Saito, Yasuhisa Fujii. Novel three-dimensional image system for transurethral surgery. Int. J. Urol.. 2015.07; 22 (7): 714-715. ( PubMed, DOI )

  201. Tatsuro Hayashi, Takeshi Yuasa, Sho Uehara, Yasushi Inoue, Shinya Yamamoto, Hitoshi Masuda, Yasuhisa Fujii, Iwao Fukui, Junji Yonese. Clinical outcome of urachal cancer in Japanese patients. Int. J. Clin. Oncol.. 2015.07; ( PubMed, DOI )

  202. Soichiro Yoshida, Naotaka Fukui, Kazutaka Saito, Yasuhisa Fujii, Yukio Kageyama, Kazunori Kihara. Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery. Int. J. Urol.. 2015.05; 22 (5): 520-521. ( PubMed, DOI )

  203. Soichiro Yoshida, Masaya Ito, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Multitask Imaging Monitor for Surgical Navigation: Combination of Touchless Interface and Head-Mounted Display. Urol. Int.. 2015.04; ( PubMed, DOI )

  204. Kazunori Kihara, Fumitaka Koga, Yasuhisa Fujii, Hitoshi Masuda, Manabu Tatokoro, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Junichiro Ishioka, Kazutaka Saito. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy for peripheral renal tumors: perioperative outcomes. Int. J. Urol.. 2015.04; 22 (4): 349-355. ( PubMed, DOI )

  205. Masaya Ito, Kazunori Kihara, Soichiro Yoshida, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display Urology Case Reports. 2015.03; 3 (2): 27-29. ( DOI )

  206. Yamamoto Shinya, Masuda Hitoshi, Urakami Shinji, Fujii Yasuhisa, Sakamoto Kimihiko, Kozuka Takuyo, Oguchi Masahiko, Fukui Iwao, Yonese Junji. Patient-perceived Satisfaction After Definitive Treatment for Men With High-risk Prostate Cancer: Radical Prostatectomy vs Intensity-modulated Radiotherapy With Androgen Deprivation Therapy. Urology. 2015.02; 85 (2): 407-414. ( PubMed, DOI )

  207. Yasuda Yosuke, Fujii Yasuhisa, Yuasa Takeshi, Yamamoto Shinya, Yonese Junji, Fukui Iwao. Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade? Int J Urol. 2015.01; 22 (1): 132-133. ( PubMed, DOI )

  208. Inoue Masaharu, Kihara Kazunori, Yoshida Soichiro, Ito Masaya, Takeshita Hideki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. A novel approach to patient self-monitoring of sonographic examinations using a head-mounted display. J Ultrasound Med. 2015.01; 34 (1): 29-35. ( PubMed, DOI )

  209. Masashi Nagata, Yasuyoshi Ishiwata, Yutaka Takahashi, Hiromitsu Takahashi, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara, Masato Yasuhara. Pharmacokinetic-pharmacodynamic analysis of sunitinib-induced thrombocytopenia in Japanese patients with renal cell carcinoma. Biol. Pharm. Bull.. 2015; 38 (3): 402-410. ( PubMed, DOI )

  210. Sho Uehara, Takeshi Yuasa, Yasuhisa Fujii, Akihiro Yano, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui, Junji Yonese. Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer. BMC Res Notes. 2015; 8 335. ( PubMed, DOI )

  211. Takeshi Yuasa, Naoko Inoshita, Akio Saiura, Shinya Yamamoto, Shinji Urakami, Hitoshi Masuda, Yasuhisa Fujii, Iwao Fukui, Yuichi Ishikawa, Junji Yonese. Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer. 2015; 15 46. ( PubMed, DOI )

  212. Matsuoka Yoh, Kihara Kazunori, Kawashima Kenji, Fujii Yasuhisa. Integrated image navigation system using head-mounted display in "RoboSurgeon" endoscopic radical prostatectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 613-618. ( PubMed, DOI )

  213. Yamamoto Shinya, Kawakami Satoru, Yonese Junji, Fujii Yasuhisa, Urakami Shinji, Kitsukawa Shinichi, Masuda Hitoshi, Ishikawa Yuichi, Kozuka Takuyo, Oguchi Masahiko, Kohno Atsushi, Fukui Iwao. Long-term oncological outcome in men with T3 prostate cancer: radical prostatectomy versus external-beam radiation therapy at a single institution. Int J Clin Oncol. 2014.12; 19 (6): 1085-1091. ( PubMed, DOI )

  214. Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma. Int J Urol. 2014.12; 21 (12): 1190-1200. ( PubMed, DOI )

  215. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa. A head-mounted display-based personal integrated-image monitoring system for transurethral resection of the prostate. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 644-649. ( PubMed, DOI )

  216. Fujii Yasuhisa, Kihara Kazunori, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka. A three-dimensional head-mounted display system (RoboSurgeon system) for gasless laparoendoscopic single-port partial cystectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 638-643. ( PubMed, DOI )

  217. Kihara Kazunori, Saito Kazutaka, Komai Yoshinobu, Fujii Yasuhisa. Integrated image monitoring system using head-mounted display for gasless single-port clampless partial nephrectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 634-637. ( PubMed, DOI )

  218. Fukushima Hiroshi, Saito Kazutaka, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Yonese Junji, Kamata Shigeyoshi, Nagahama Katsushi, Noro Akira, Morimoto Shinji, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Higashi Yotsuo, Kihara Kazunori. Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study. Int J Urol. 2014.11; 21 (11): 1098-1104. ( PubMed, DOI )

  219. Ishioka Junichiro, Kihara Kazunori, Higuchi Saori, Nakayama Takayuki, Takeshita Hideki, Yoshida Soichiro, Nakanishi Yasukazu, Kijima Toshiki, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. New head-mounted display system applied to endoscopic management of upper urinary tract carcinomas. Int Braz J Urol. 2014.11; 40 (6): 842-845. ( PubMed )

  220. Kondo Tsunenori, Nakazawa Hayakazu, Oya Mototsugu, Kimura Go, Fujii Yasuhisa, Hatano Takashi, Kawata Nozomu, Kume Haruki, Morita Masashi, Nakajima Koichi, Ohno Yoshio, Okegawa Takatsugu, Takahashi Shunji, Wakumoto Yoshiaki, Horie Shigeo. Clinical efficacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib. Jpn J Clin Oncol. 2014.11; ( PubMed, DOI )

  221. Ishioka Junichiro, Masuda Hitoshi, Kijima Toshiki, Tatokoro Manabu, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Nagahama Katsuhi, Kamata Shigeyoshi, Yonese Junji, Kageyama Yukio, Noro Akira, Morimoto Shinji, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Kihara Kazunori. Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients. Anticancer Res. 2014.10; 34 (10): 5683-5688. ( PubMed )

  222. Inoue Masaharu, Koga Fumitaka, Yoshida Soichiro, Tamura Tomoki, Fujii Yasuhisa, Ito Eisaku, Kihara Kazunori. Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. Int J Radiat Oncol Biol Phys. 2014.10; 90 (2): 303-311. ( PubMed, DOI )

  223. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa. Instructive head-mounted display system: pointing device using a vision-based finger tracking technique applied to surgical education. Wideochir Inne Tech Malo Inwazyjne. 2014.09; 9 (3): 449-452. ( PubMed, DOI )

  224. Uchida Y, Yoshida S, Kobayashi S, Koga F, Ishioka J, Satoh S, Ishii C, Tanaka H, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K.. Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer. Br J Radiol. 2014.08; 87 ( PubMed )

  225. Nakayama Takayuki, Saito Kazutaka, Fujii Yasuhisa, Abe-Suzuki Shiho, Nakanishi Yasukazu, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Kihara Kazunori. Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy. Jpn J Clin Oncol. 2014.08; 44 (8): 756-761. ( PubMed, DOI )

  226. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. Head-Mounted Display for a Personal Integrated Image Monitoring System: Ureteral Stent Placement. Urol Int. 2014.08; ( PubMed, DOI )

  227. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Ishioka Junichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori. Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy. BJU Int. 2014.08; ( PubMed, DOI )

  228. Takeshita Hideki, Kihara Kazunori, Yoshida Soichiro, Higuchi Saori, Ito Masaya, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. Clinical application of a modern high-definition head-mounted display in sonography. J Ultrasound Med. 2014.08; 33 (8): 1499-1504. ( PubMed, DOI )

  229. Koga Fumitaka, Kobayashi Shuichiro, Fujii Yasuhisa, Ishioka Junichiro, Yokoyama Minato, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Kihara Kazunori. Significance of positive urine cytology on progression and cancer-specific mortality of non--muscle-invasive bladder cancer. Clin Genitourin Cancer. 2014.06; 12 (3): e87-e93. ( PubMed, DOI )

  230. Yamamoto Shinya, Fujii Yasuhisa, Masuda Hitoshi, Urakami Shinji, Saito Kazutaka, Kozuka Takuyo, Oguchi Masahiko, Fukui Iwao, Yonese Junji. Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer. Qual Life Res. 2014.06; 23 (5): 1641-1650. ( PubMed, DOI )

  231. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Tanaka Hiroshi, Satoh Shiro, Fujii Yasuhisa, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World J Radiol. 2014.06; 6 (6): 344-354. ( PubMed, DOI )

  232. Takeshita Hideki, Kawakami Satoru, Numao Noboru, Sakura Mizuaki, Tatokoro Manabu, Yamamoto Shinya, Kijima Toshiki, Komai Yoshinobu, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Fukui Iwao, Kihara Kazunori. Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method. BJU Int. 2014.04; ( PubMed, DOI )

  233. Bae Hyeyeol, Yoshida Soichiro, Matsuoka Yoh, Nakajima Hiroshi, Ito Eisaku, Tanaka Hiroshi, Oya Miyako, Nakayama Takayuki, Takeshita Hideki, Kijima Toshiki, Ishioka Junichiro, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Akashi Takumi, Fujii Yasuhisa, Kihara Kazunori. Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. Int Urol Nephrol. 2014.03; 46 (3): 555-561. ( PubMed, DOI )

  234. Yokoyama Minato, Fujii Yasuhisa, Takeshita Hideki, Kawamura Naoko, Nakayama Takayuki, Iimura Yasumasa, Sakura Mizuaki, Ishioka Junichiro, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Noro Akira, Arisawa Chizuru, Kitahara Satoshi, Kihara Kazunori. Renal function after radical nephrectomy: development and validation of predictive models in Japanese patients. Int J Urol. 2014.03; 21 (3): 238-242. ( PubMed, DOI )

  235. Nakayama Takayuki, Saito Kazutaka, Ishioka Junichiro, Kawano Keizo, Morimoto Shinji, Matsuoka Yoh, Okuno Tetsuo, Moriyama Shingo, Takeshita Hideki, Noro Akira, Fujii Yasuhisa, Kihara Kazunori. External validation of TNM-C score in three community hospital cohorts for clear cell renal cell carcinoma. Anticancer Res. 2014.02; 34 (2): 921-926. ( PubMed )

  236. Ishioka Junichiro, Saito Kazutaka, Kijima Toshiki, Nakanishi Yasukazu, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Nagahama Katsuhi, Kamata Shigeyoshi, Sakura Mizuaki, Yonese Junji, Morimoto Shinji, Noro Akira, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Higashi Yotsuo, Kihara Kazunori. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2014.02; ( PubMed, DOI )

  237. Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Masuda Hitoshi, Urakami Shinji, Kitsukawa Shinichi, Sakura Mizuaki, Yuasa Takeshi, Kihara Kazunori, Fukui Iwao. The processus vaginalis transection method to prevent postradical prostatectomy inguinal hernia: long-term results. Urology. 2014.01; 83 (1): 247-252. ( PubMed, DOI )

  238. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol. 2014.01; 65 (1): 186-192. ( PubMed, DOI )

  239. Urakami Shinji, Fujii Yasuhisa, Yamamoto Shinya, Yuasa Takeshi, Kitsukawa Shinichi, Sakura Mizuaki, Yano Akihiro, Saito Kazutaka, Masuda Hitoshi, Yonese Junji, Fukui Iwao. Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma. Urol Oncol. 2014.01; 32 (1): 35.e1-35.e7. ( PubMed, DOI )

  240. Kobayashi Shuichiro, Fujii Yasuhisa, Koga Fumitaka, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Kihara Kazunori. Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: a prospective validation study. Urol Oncol. 2014.01; 32 (1): 38.e29-38.e36. ( PubMed, DOI )

  241. Kobayashi Shuichiro, Koga Fumitaka, Kajino Kohei, Yoshita Soichiro, Ishii Chikako, Tanaka Hiroshi, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamada Tetsuo, Kihara Kazunori. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging. 2014.01; 39 (1): 172-178. ( PubMed, DOI )

  242. Yachida Yuki, Yoshida Soichiro, Takeshita Hideki, Sawamura Chigusa, Tanaka Hiroshi, Satoh Shiro, Uchida Yusuke, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori. Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect? Urol Int. 2014; 93 (2): 170-175. ( PubMed, DOI )

  243. Ito Masaya, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Koga Fumitaka, Saito Kazutaka, Yamamoto Shinya, Yonese Junji, Fukui Iwao, Kihara Kazunori. Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10 ng/mL and non-suspicious digital rectal examination. Int J Urol. 2013.12; 20 (12): 1163-1168. ( PubMed, DOI )

  244. Koga Fumitaka, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients. Urol Oncol. 2013.10; 31 (7): 1270-1275. ( PubMed, DOI )

  245. Yasuda Yosuke, Fujii Yasuhisa, Yuasa Takeshi, Kitsukawa Shinichi, Urakami Shinji, Yamamoto Shinya, Yonese Junji, Takahashi Shunji, Fukui Iwao. Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma. Int J Clin Oncol. 2013.10; 18 (5): 877-883. ( PubMed, DOI )

  246. Komai Yoshinobu, Numao Noboru, Yoshida Soichiro, Matsuoka Yoh, Nakanishi Yasukazu, Ishii Chikako, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol. 2013.09; 190 (3): 867-873. ( PubMed, DOI )

  247. Numao Noboru, Yoshida Soichiro, Komai Yoshinobu, Ishii Chikako, Kagawa Makoto, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol. 2013.08; 190 (2): 502-508. ( PubMed, DOI )

  248. Yoshida Soichiro, Kobayashi Shuichiro, Koga Fumitaka, Ishioka Junichiro, Ishii Chikako, Tanaka Hiroshi, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. Eur Radiol. 2013.08; 23 (8): 2206-2214. ( PubMed, DOI )

  249. Fukushima Hiroshi, Masuda Hitoshi, Yokoyama Minato, Tatokoro Manabu, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Jpn J Clin Oncol. 2013.07; 43 (7): 740-746. ( PubMed, DOI )

  250. Takeshita Hideki, Numao Noboru, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Yamamoto Shinya, Yonese Junji, Fujii Yasuhisa, Kihara Kazunori. Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer. Int Urol Nephrol. 2013.06; 45 (3): 645-652. ( PubMed, DOI )

  251. Masuda Hitoshi, Fukushima Hiroshi, Kawakami Satoru, Numao Noboru, Fujii Yasuhisa, Saito Kazutaka, Koga Fumitaka, Ishioka Junichiro, Yokoyama Minato, Kihara Kazunori. Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage. Jpn J Clin Oncol. 2013.04; 43 (4): 410-416. ( PubMed, DOI )

  252. Tanaka Hajime, Yuasa Takeshi, Fujii Yasuhisa, Sakura Mizuaki, Urakami Shinji, Yamamoto Shinya, Masuda Hitoshi, Fukui Iwao, Yonese Junji. First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era. Chemotherapy. 2013; 59 (6): 441-446. ( PubMed, DOI )

  253. Kijima Toshiki, Koga Fumitaka, Fujii Yasuhisa, Yoshida Soichiro, Tatokoro Manabu, Kihara Kazunori. Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1. PLoS One. 2013; 8 (5): e64615. ( PubMed, DOI )

  254. Tatokoro Manabu, Kihara Kazunori, Masuda Hitoshi, Ito Masaya, Yoshida Soichiro, Kijima Toshiki, Yokoyama Minato, Saito Kazutaka, Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study. BMC Urol. 2013; 13 35. ( PubMed, DOI )

  255. Hirono Masanori, Kobayashi Mikio, Tsushima Tomoyasu, Obara Wataru, Shinohara Nobuo, Ito Keiichi, Eto Masatoshi, Takayama Tatsuya, Fujii Yasuhisa, Nishikido Masaharu, Kimura Go, Kishida Takeshi, Takahashi Masayuki, Miyao Noriomi, Naya Yukio, Abe Takashige, Fujioka Tomoaki, Ito Kazuto, Naito Seiji, Members of the Japanese Society of Renal Cancer. Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan. BMC Cancer. 2013; 13 447. ( PubMed, DOI )

  256. Waseda Yuma, Komai Yoshinobu, Yano Akihiro, Fujii Yasuhisa, Noguchi Norio, Kihara Kazunori. Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report. Jpn J Clin Oncol. 2012.12; 42 (12): 1197-1201. ( PubMed, DOI )

  257. Komai Yoshinobu, Kawakami Satoru, Numao Noboru, Fujii Yasuhisa, Saito Kazutaka, Kubo Yuichi, Koga Fumitaka, Kumagai Jiro, Yamamoto Shinya, Yonese Junji, Ishikawa Yuichi, Fukui Iwao, Kihara Kazunori. Extended biopsy based criteria incorporating cumulative cancer length for predicting clinically insignificant prostate cancer. BJU Int. 2012.12; 110 (11 Pt B): E564-E569. ( PubMed, DOI )

  258. Kijima Toshiki, Fujii Yasuhisa, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer. BJU Int. 2012.10; 110 (8): 1149-1155. ( PubMed, DOI )

  259. Masuda Hitoshi, Kawakami Satoru, Sakura Mizuaki, Fujii Yasuhisa, Koga Fumitaka, Saito Kazutaka, Numao Noboru, Yonese Junji, Fukui Iwao, Kihara Kazunori. Performance of prostate-specific antigen mass in estimation of prostate volume in Japanese men with benign prostate hyperplasia. Int J Urol. 2012.10; 19 (10): 929-935. ( PubMed, DOI )

  260. Koga Fumitaka, Fujii Yasuhisa, Masuda Hitoshi, Numao Noboru, Yokoyama Minato, Ishioka Jun-ichiro, Saito Kazutaka, Kawakami Satoru, Kihara Kazunori. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches. BJU Int. 2012.09; 110 (6 Pt B): E203-E208. ( PubMed, DOI )

  261. Nakanishi Yasukazu, Masuda Hitoshi, Kawakami Satoru, Sakura Mizuaki, Fujii Yasuhisa, Saito Kazutaka, Koga Fumitaka, Ito Masaya, Yonese Junji, Fukui Iwao, Kihara Kazunori. A novel equation and nomogram including body weight for estimating prostate volumes in men with biopsy-proven benign prostatic hyperplasia. Asian J Androl. 2012.09; 14 (5): 703-707. ( PubMed, DOI )

  262. Kijima Toshiki, Masuda Hitoshi, Yoshida Soichiro, Tatokoro Manabu, Yokoyama Minato, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Kihara Kazunori. Antimicrobial prophylaxis is not necessary in clean category minimally invasive surgery for renal and adrenal tumors: a prospective study of 373 consecutive patients. Urology. 2012.09; 80 (3): 570-575. ( PubMed, DOI )

  263. Kihara Kazunori, Fujii Yasuhisa, Masuda Hitoshi, Saito Kazutaka, Koga Fumitaka, Matsuoka Yoh, Numao Noboru, Kojima Kazuyuki. New three-dimensional head-mounted display system, TMDU-S-3D system, for minimally invasive surgery application: procedures for gasless single-port radical nephrectomy. Int J Urol. 2012.09; 19 (9): 886-889. ( PubMed, DOI )

  264. Takeshita Hideki, Yokoyama Minato, Fujii Yasuhisa, Chiba Koji, Ishioka Junichiro, Noro Akira, Kihara Kazunori. Impact of renal function on cardiovascular events in patients undergoing radical nephrectomy for renal cancer. Int J Urol. 2012.08; 19 (8): 722-728. ( PubMed, DOI )

  265. Tatokoro Manabu, Koga Fumitaka, Yoshida Soichiro, Kawakami Satoru, Fujii Yasuhisa, Neckers Len, Kihara Kazunori. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer. 2012.08; 131 (4): 987-996. ( PubMed, DOI )

  266. Ishioka J, Saito K, Sakura M, Yokoyama M, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Kawakami S, Kihara K.. Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis. Br J Cancer. 2012.07; 107 (7): 1031-1036. ( PubMed )

  267. Fukushima Hiroshi, Masuda Hitoshi, Kawakami Satoru, Ito Masaya, Sakura Mizuaki, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Fukui Iwao, Kihara Kazunori. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology. 2012.06; 79 (6): 1329-1334. ( PubMed, DOI )

  268. Yamamoto Shinya, Kawakami Satoru, Yonese Junji, Fujii Yasuhisa, Urakami Shinji, Masuda Hitoshi, Numao Noboru, Ishikawa Yuichi, Kohno Atsushi, Fukui Iwao. Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy. Jpn J Clin Oncol. 2012.06; 42 (6): 541-547. ( PubMed, DOI )

  269. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Ishii Chikako, Tanaka Hiroshi, Tanaka Hajime, Komai Yoshinobu, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2012.05; 83 (1): e21-e27. ( PubMed, DOI )

  270. Koga Fumitaka, Kihara Kazunori, Yoshida Soichiro, Yokoyama Minato, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU Int. 2012.03; 109 (6): 860-866. ( PubMed, DOI )

  271. Numao Noboru, Kawakami Satoru, Sakura Mizuaki, Yoshida Soichiro, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Ishikawa Yuichi, Fukui Iwao, Kihara Kazunori. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU Int. 2012.03; 109 (5): 665-671. ( PubMed, DOI )

  272. Inamura Kentaro, Fujiwara Mutsunori, Togashi Yuki, Nomura Kimie, Mukai Hiroyuki, Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Fukui Iwao, Ishikawa Yuichi. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation. Am J Surg Pathol. 2012.01; 36 (1): 35-42. ( PubMed, DOI )

  273. Takeshi Yuasa, Yasuhisa Fujii, Shunji Takahashi, Iwao Fukui, Junji Yonese. Molecular Targeted Therapies for Patients with Metastatic Renal Cell Cancer. Translational Medic. 2012; (S2):

  274. Iwai Aki, Koga Fumitaka, Fujii Yasuhisa, Masuda Hitoshi, Saito Kazutaka, Numao Noboru, Sakura Mizuaki, Kawakami Satoru, Kihara Kazunori. Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy. Jpn J Clin Oncol. 2011.12; 41 (12): 1373-1379. ( PubMed, DOI )

  275. Yoshida Soichiro, Koga Fumitaka, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori. Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy. Cell Cycle. 2011.12; 10 (24): 4291-4299. ( PubMed, DOI )

  276. Kobayashi Shuichiro, Koga Fumitaka, Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Komai Yoshinobu, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. 2011.10; 21 (10): 2178-2186. ( PubMed, DOI )

  277. Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa, Ishii Chikako, Tanaka Hiroshi, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011.10; 18 (10): 727-730. ( PubMed, DOI )

  278. Yokoyama Minato, Fujii Yasuhisa, Iimura Yasumasa, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Longitudinal change in renal function after radical nephrectomy in Japanese patients with renal cortical tumors. J Urol. 2011.06; 185 (6): 2066-2071. ( PubMed, DOI )

  279. Sakura Mizuaki, Kawakami Satoru, Ishioka Junichiro, Fujii Yasuhisa, Yamamoto Shinya, Iwai Aki, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kumagai Jiro, Yonese Junji, Fukui Iwao, Kihara Kazunori. A novel repeat biopsy nomogram based on three-dimensional extended biopsy. Urology. 2011.04; 77 (4): 915-920. ( PubMed, DOI )

  280. Komai Yoshinobu, Fujii Yasuhisa, Iimura Yasumasa, Tatokoro Manabu, Saito Kazutaka, Otsuka Yukihiro, Koga Fumitaka, Arisawa Chizuru, Kawakami Satoru, Okuno Tetsuo, Tsujii Toshihiko, Kageyama Yukio, Morimoto Shinji, Toma Tsuguhiro, Higashi Yotsuo, Fukui Iwao, Kihara Kazunori. Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology. 2011.04; 77 (4): 842-847. ( PubMed, DOI )

  281. Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR Am J Roentgenol. 2011.01; 196 (1): 110-116. ( PubMed, DOI )

  282. Tatokoro Manabu, Fujii Yasuhisa, Kawakami Satoru, Saito Kazutaka, Koga Fumitaka, Matsuoka Yoh, Iimura Yasumasa, Masuda Hitoshi, Kihara Kazunori. Phase-II trial of combination treatment of interferon-alpha, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma. Cancer Sci. 2011.01; 102 (1): 137-143. ( PubMed, DOI )

  283. Koga Fumitaka, Yoshida Soichiro, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori. ErbB2 and NFkappaB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer. PLoS One. 2011; 6 (11): e27616. ( PubMed, DOI )

  284. Yamamoto Shinya, Kawakami Satoru, Yonese Junji, Fujii Yasuhisa, Tsukamoto Tetsuro, Okubo Yuhei, Kijima Toshiki, Ishikawa Yuichi, Fukui Iwao. Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease. Int J Urol. 2010.08; 17 (8): 720-725. ( PubMed, DOI )

  285. Fujii Yasuhisa. Benign lesions at surgery for presumed renal cell carcinoma: an Asian perspective. Int J Urol. 2010.06; 17 (6): 500. ( PubMed, DOI )

  286. Suzuki Hiroyoshi, Hinotsu Shiro, Akaza Hideyuki, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori, Akakura Koichiro, Suzuki Motofumi, Kitamura Tadaichi, Homma Yukio, Mizokami Atsushi. Hormonal therapy for prostate cancer: current topics and future perspectives. Int J Urol. 2010.04; 17 (4): 302-313. ( PubMed, DOI )

  287. Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Kawakami Satoru, Okubo Yuhei, Suyama Taisuke, Komai Yoshinobu, Kijima Toshiki, Fukui Iwao. A novel technique to prevent postradical retropubic prostatectomy inguinal hernia: the processus vaginalis transection method. Urology. 2010.03; 75 (3): 713-717. ( PubMed, DOI )

  288. Yoshida Soichiro, Koga Fumitaka, Kawakami Satoru, Ishii Chikako, Tanaka Hiroshi, Numao Noboru, Sakai Yasuyuki, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology. 2010.02; 75 (2): 387-391. ( PubMed, DOI )

  289. Kihara K, Kobayashi T, Kawakami S, Fujii Y, Kageyama Y, Masuda H. Minimum incision endoscopic surgery (MIES) in Japanese urology: results of adrenalectomy, radical nephrectomy and radical prostatectomy. Aktuelle Urol. 2010; 41 (Suppl 1): S15-S19.

  290. Suzuki Masahito, Kawakami Satoru, Asano Touko, Masuda Hitoshi, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Kihara Kazunori. Safety of transperineal 14-core systematic prostate biopsy in diabetic men. Int J Urol. 2009.12; 16 (12): 930-935. ( PubMed, DOI )

  291. Fukushima Hiroshi, Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa, Yoshida Soichiro, Ratovitski Edward, Trink Barry, Kihara Kazunori. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway. Cancer Res. 2009.12; 69 (24): 9263-9270. ( PubMed, DOI )

  292. Kihara Kazunori, Kawakami Satoru, Fujii Yasuhisa, Masuda Hitoshi, Koga Fumitaka. Gasless single-port access endoscopic surgery in urology: minimum incision endoscopic surgery, MIES. Int J Urol. 2009.10; 16 (10): 791-800. ( PubMed, DOI )

  293. Koga Fumitaka, Kihara Kazunori, Fujii Yasuhisa, Yoshida Soichiro, Saito Kazutaka, Masuda Hitoshi, Kageyama Yukio, Kawakami Satoru. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009.07; 104 (2): 189-194. ( PubMed, DOI )

  294. Yamamoto Shinya, Kawakami Satoru, Yonese Junji, Fujii Yasuhisa, Tsukamoto Tetsuro, Ohkubo Yuhei, Komai Yoshinobu, Ishikawa Yuichi, Fukui Iwao. Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resection. Jpn J Clin Oncol. 2009.06; 39 (6): 387-393. ( PubMed, DOI )

  295. Saito Kazutaka, Tatokoro Manabu, Fujii Yasuhisa, Iimura Yasumasa, Koga Fumitaka, Kawakami Satoru, Kihara Kazunori. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Eur Urol. 2009.05; 55 (5): 1145-1153. ( PubMed, DOI )

  296. Kubo Yuichi, Kawakami Satoru, Numao Noboru, Takazawa Ryoji, Fujii Yasuhisa, Masuda Hitoshi, Tsujii Toshihiko, Kihara Kazunori. Simple and effective local anesthesia for transperineal extended prostate biopsy: application to three-dimensional 26-core biopsy. Int J Urol. 2009.04; 16 (4): 420-423. ( PubMed, DOI )

  297. Iimura Yasumasa, Saito Kazutaka, Fujii Yasuhisa, Kumagai Jiro, Kawakami Satoru, Komai Yoshinobu, Yonese Junji, Fukui Iwao, Kihara Kazunori. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol. 2009.03; 181 (3): 1004-12; discussion 1012. ( PubMed, DOI )

  298. Kijima Toshiki, Fujii Yasuhisa, Suyama Taisuke, Okubo Yuhei, Yamamoto Shinya, Masuda Hitoshi, Yonese Junji, Fukui Iwao. Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int. 2009.03; 103 (5): 620-624. ( PubMed, DOI )

  299. Komai Yoshinobu, Fujiwara Mutsunori, Fujii Yasuhisa, Mukai Hiroyuki, Yonese Junji, Kawakami Satoru, Yamamoto Shinya, Migita Toshiro, Ishikawa Yuichi, Kurata Morito, Nakamura Takuro, Fukui Iwao. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res. 2009.02; 15 (4): 1170-1176. ( PubMed, DOI )

  300. Yokoyama Minato, Fujii Yasuhisa, Yoshida Soichiro, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. Int J Urol. 2009.01; 16 (1): 61-63. ( PubMed, DOI )

  301. Yamamoto Shinya, Kawakami Satoru, Yonese Junji, Fujii Yasuhisa, Tsukamoto Tetsuro, Ohkubo Yuhei, Komai Yoshinobu, Ishikawa Yuichi, Fukui Iwao. Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer. Urology. 2008.12; 72 (6): 1224-1228. ( PubMed, DOI )

  302. Numao Noboru, Kawakami Satoru, Yonese Junji, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Ishikawa Yuichi, Fukui Iwao, Kihara Kazunori. Three-dimensional 26-core biopsy-based patient selection criteria for nerve-sparing radical prostatectomy. Int J Urol. 2008.12; 15 (12): 1061-1066. ( PubMed, DOI )

  303. Kawakami Satoru, Koga Fumitaka, Fujii Yasuhisa, Saito Kazutaka, Yamamoto Shinya, Tatokoro Manabu, Yonese Junji, Kageyama Yukio, Fukui Iwao, Kihara Kazunori. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. Int J Urol. 2008.12; 15 (12): 1055-1060. ( PubMed, DOI )

  304. Fujii Yasuhisa, Saito Kazutaka, Iimura Yasumasa, Sakai Yasuyuki, Koga Fumitaka, Kawakami Satoru, Kumagai Jiro, Kihara Kazunori. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma. J Urol. 2008.10; 180 (4): 1290-5; discussion 1295. ( PubMed, DOI )

  305. Komai Yoshinobu, Fujii Yasuhisa, Okubo Yuhei, Yamamoto Shinya, Kawakami Satoru, Yonese Junji, Fukui Iwao. Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy. Int J Urol. 2008.10; 15 (11): 971-975. ( PubMed, DOI )

  306. Yamamoto Shinya, Kawakami Satoru, Yonese Junji, Fujii Yasuhisa, Ohkubo Yuhei, Suyama Taisuke, Komai Yoshinobu, Kijima Toshiki, Ishikawa Yuichi, Fukui Iwao. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer. Int J Urol. 2008.10; 15 (10): 895-899. ( PubMed, DOI )

  307. Kawakami Satoru, Numao Noboru, Okubo Yuhei, Koga Fumitaka, Yamamoto Shinya, Saito Kazutaka, Fujii Yasuhisa, Yonese Junji, Masuda Hitoshi, Kihara Kazunori, Fukui Iwao. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur Urol. 2008.09; 54 (3): 601-611. ( PubMed, DOI )

  308. Tatokoro Manabu, Kawakami Satoru, Yonese Junji, Fujii Yasuhisa, Okubo Yuhei, Yamamoto Shinya, Takeshita Hideki, Komai Yoshinobu, Ishikawa Yuichi, Fukui Iwao. Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus. Int J Urol. 2008.09; 15 (9): 851-853. ( PubMed, DOI )

  309. Tatokoro Manabu, Fujii Yasuhisa, Kawakami Satoru, Fukui Naotaka, Komai Yoshinobu, Saito Kazutaka, Koga Fumitaka, Morimoto Shinji, Fukui Iwao, Kihara Kazunori. Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: Report of three cases. Int J Urol. 2008.09; 15 (9): 848-850. ( PubMed, DOI )

  310. Fujii Yasuhisa, Komai Yoshinobu, Saito Kazutaka, Iimura Yasumasa, Yonese Junji, Kawakami Satoru, Ishikawa Yuichi, Kumagai Jiro, Kihara Kazunori, Fukui Iwao. Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology. 2008.09; 72 (3): 598-602. ( PubMed, DOI )

  311. Koga Fumitaka, Yoshida Soichiro, Kawakami Satoru, Kageyama Yukio, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kobayashi Tsuyoshi, Kihara Kazunori. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008.08; 72 (2): 384-388. ( PubMed, DOI )

  312. Tatokoro Manabu, Saito Kazutaka, Iimura Yasumasa, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. J Urol. 2008.08; 180 (2): 515-519. ( PubMed, DOI )

  313. Ishioka Jun-Ichiro, Fujii Yasuhisa, Kageyama Yukio, Fukuda Hiroshi, Higashi Yotsuo, Kihara Kazunori. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors. Int J Urol. 2008.07; 15 (7): 642-645. ( PubMed, DOI )

  314. Kijima Toshiki, Fujii Yasuhisa, Suyama Taisuke, Okubo Yuhei, Yonese Junji, Fukui Iwao. Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report. Int J Urol. 2008.06; 15 (6): 546-547. ( PubMed, DOI )

  315. Yoshida Soichiro, Fujii Yasuhisa, Yokoyama Minato, Ishii Chikako, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. Female urethral diverticular abscess clearly depicted by diffusion-weighted magnetic resonance imaging. Int J Urol. 2008.05; 15 (5): 460-461. ( PubMed, DOI )

  316. Fujii Yasuhisa, Yonese Junji, Kawakami Satoru, Yamamoto Shinya, Okubo Yuhei, Fukui Iwao. Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer. BJU Int. 2008.05; 101 (9): 1096-1100. ( PubMed, DOI )

  317. Saito Kazutaka, Kawakami Satoru, Fujii Yasuhisa, Sakura Mizuaki, Masuda Hitoshi, Kihara Kazunori. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol. 2007.12; 178 (6): 2291-6; discussion 2296. ( PubMed, DOI )

  318. Takeshita Hideki, Yonese Junji, Fujii Yasuhisa, Kawakami Satoru, Komai Yoshinobu, Ohkubo Yuhei, Yamamoto Shinya, Ishikawa Yuichi, Seto Yasuyuki, Ohyama Shigekazu, Fukui Iwao. Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor. Int J Clin Oncol. 2007.12; 12 (6): 485-487. ( PubMed, DOI )

  319. Saito Kazutaka, Kawakami Satoru, Ohtsuka Yukihiro, Fujii Yasuhisa, Masuda Hitoshi, Kumagai Jiro, Kobayashi Tsuyoshi, Kageyama Yukio, Kihara Kazunori. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int. 2007.08; 100 (2): 269-273. ( PubMed, DOI )

  320. Winters Stephen J, Ghooray Dushan, Fujii Yasuhisa, Moore Joseph P Jr, Nevitt Jennifer R, Kakar Sham S. Transcriptional regulation of follistatin expression by GnRH in mouse gonadotroph cell lines: evidence for a role for cAMP signaling. Mol Cell Endocrinol. 2007.06; 271 (1-2): 45-54. ( PubMed, DOI )

  321. Kawakami Satoru, Okuno Tetsuo, Yonese Junji, Igari Toru, Arai Gaku, Fujii Yasuhisa, Kageyama Yukio, Fukui Iwao, Kihara Kazunori. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy. Eur Urol. 2007.03; 51 (3): 675-82; discussion 682. ( PubMed, DOI )

  322. Yano Akihiro, Fujii Yasuhisa, Iwai Aki, Kawakami Satoru, Kageyama Yukio, Kihara Kazunori. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells. Clin Cancer Res. 2006.10; 12 (20 Pt 1): 6012-6017. ( PubMed, DOI )

  323. 浅野 桐子, 藤井 靖久, 沼尾 昇, 影山 幸雄, 木原 和徳. 柴苓湯が有効であった後腹膜線維症の2例 泌尿器科紀要. 2006.07; 52 (7): 543-547. ( ichushi )

  324. Asano Touko, Fujii Yasuhisa, Numao Noboru, Kageyama Yukio, Kihara Kazunori. The efficiency of Sairei-to for retroperitoneal fibrosis: two case reports. Hinyokika Kiyo. 2006.07; 52 (7): 543-547. ( PubMed )

  325. Ohtsuka Yukihiro, Kawakami Satoru, Fujii Yasuhisa, Koga Fumitaka, Saito Kazutaka, Ando Noboru, Takizawa Touichiro, Kageyama Yukio, Kihara Kazunori. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract. BJU Int. 2006.06; 97 (6): 1322-1326. ( PubMed, DOI )

  326. Fujii Yasuhisa, Kawakami Satoru, Masuda Hitoshi, Kobayashi Tsuyoshi, Hyochi Nobuhiko, Kageyama Yukio, Kihara Kazunori. Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy. BJU Int. 2006.06; 97 (6): 1184-1189. ( PubMed, DOI )

  327. Yano Akihiro, Fujii Yasuhisa, Iwai Aki, Kageyama Yukio, Kihara Kazunori. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res. 2006.05; 12 (10): 3003-3009. ( PubMed, DOI )

  328. Kawakami Satoru, Hyochi Nobuhiko, Yonese Junji, Yano Masataka, Fujii Yasuhisa, Kageyama Yukio, Fukui Iwao, Kihara Kazunori. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int J Clin Oncol. 2006.04; 11 (2): 127-132. ( PubMed, DOI )

  329. Kageyama Yukio, Sugiyama Hiroshi, Ayame Hirohito, Iwai Aki, Fujii Yasuhisa, Huang L Eric, Kizaka-Kondoh Shinae, Hiraoka Masahiro, Kihara Kazunori. Suppression of VEGF transcription in renal cell carcinoma cells by pyrrole-imidazole hairpin polyamides targeting the hypoxia responsive element. Acta Oncol. 2006; 45 (3): 317-324. ( PubMed, DOI )

  330. Furutani Yutaka, Kato Akira, Fibriani Azzania, Hirata Taku, Kawai Ryoji, Jeon Ju-Hong, Fujii Yasuhisa, Kim In-Gyu, Kojima Soichi, Hirose Shigehisa. Identification, evolution, and regulation of expression of Guinea pig trappin with an unusually long transglutaminase substrate domain. J Biol Chem. 2005.05; 280 (21): 20204-20215. ( PubMed, DOI )

  331. Tadokoro Manabu, Masuda Hitoshi, Fujii Yasuhisa, Kobayashi Tsuyoshi, Kageyama Yukio, Kihara Kazunori. Late relapse of stage I testicular seminoma metastatic to just a para-ureteropelvic region. Int J Urol. 2004.11; 11 (11): 1044-1046. ( PubMed, DOI )

  332. Iwai Aki, Fujii Yasuhisa, Kawakami Satoru, Takazawa Ryoji, Kageyama Yukio, Yoshida Mitsuaki A, Kihara Kazunori. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. Mol Cell Endocrinol. 2004.10; 226 (1-2): 11-17. ( PubMed, DOI )

  333. Kihara Kazunori, Kageyama Yukio, Yano Masataka, Kobayashi Tsuyoshi, Kawakami Satoru, Fujii Yasuhisa, Masuda Hitoshi, Hyochi Nobuhiko. Portless endoscopic radical nephrectomy via a single minimum incision in 80 patients. Int J Urol. 2004.09; 11 (9): 714-720. ( PubMed, DOI )

  334. Kageyama Yukio, Kihara Kazunori, Kobayashi Tsuyoshi, Kawakami Satoru, Fujii Yasuhisa, Masuda Hitoshi, Yano Masataka, Hyochi Nobuhiko. Portless endoscopic adrenalectomy via a single minimal incision using a retroperitoneal approach: experience with initial 30 cases. Int J Urol. 2004.09; 11 (9): 693-699. ( PubMed, DOI )

  335. Kawakami Satoru, Kihara Kazunori, Fujii Yasuhisa, Masuda Hitoshi, Kobayashi Tsuyoshi, Kageyama Yukio. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer. Int J Urol. 2004.08; 11 (8): 613-618. ( PubMed, DOI )

  336. Fujii Yasuhisa, Kawakami Satoru, Okada Yohei, Kageyama Yukio, Kihara Kazunori. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells. Am J Physiol Endocrinol Metab. 2004.06; 286 (6): E927-E931. ( PubMed, DOI )

  337. Koga Fumitaka, Kageyama Yukio, Kawakami Satoru, Fujii Yasuhisa, Hyochi Nobuhiko, Ando Noboru, Takizawa Touichiro, Saito Kazutaka, Iwai Aki, Masuda Hitoshi, Kihara Kazunori. Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer. J Urol. 2004.03; 171 (3): 1080-1084. ( PubMed, DOI )

  338. Kitayama Sachi, Fujii Yasuhisa, Kihara Kazunori. Urothelial cancer producing granulocyte colony-stimulating factor: possible induction of splenomegaly. Urology. 2004.02; 63 (2): 377-378. ( PubMed, DOI )

  339. Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa, Saito Kazutaka, Ohtsuka Yukihiro, Iwai Aki, Ando Noboru, Takizawa Touichiro, Kageyama Yukio, Kihara Kazunori. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res. 2003.11; 9 (15): 5501-5507. ( PubMed )

  340. Fujii Y, Kawakami S, Koga F, Nemoto T, Kihara K.. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int. 2003.10; 92 (6): 559-562. ( PubMed )

  341. Kageyama Yukio, Yokoyama Minato, Sakai Yasuyuki, Saito Kazutaka, Koga Fumitaka, Yano Masataka, Arai Gaku, Hyochi Nobuhiko, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kobayashi Tsuyoshi, Kihara Kazunori. Favorable outcome of preoperative low dose chemoradiotherapy against muscle-invasive bladder cancer. Am J Clin Oncol. 2003.10; 26 (5): 504-507. ( PubMed, DOI )

  342. Yokoyama Minato, Fujii Yasuhisa, Okuno Tetsuo, Kawakami Satoro, Kobayashi Tsuyushi, Masuda Hitoshi, Kageyama Yukio, Kihara Kazunori. Adenocarcinoma arising at the ileoileal anastomotic site of Scheele's ring. Int J Urol. 2003.09; 10 (9): 495-497. ( PubMed )

  343. Fujii Yasuhisa, Kageyama Yukio, Kawakami Satoru, Masuda Hitoshi, Arisawa Chizuru, Akamatsu Hideki, Akashi Takumi, Kihara Kazunori. Successful long-term disease-free survival following multimodal treatments in a patient with a repeatedly recurrent refractory adrenal cortical carcinoma. Int J Urol. 2003.08; 10 (8): 445-448. ( PubMed )

  344. Saito Kazutaka, Fujii Yasuhisa, Kawakami Satoru, Hayashi Tetsuo, Arisawa Chizuru, Koga Fumitaka, Kageyama Yukio, Kihara Kazunori. Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients. Anticancer Res. 2003.07; 23 (4): 3441-3446. ( PubMed )

  345. Kawakami S, Hyouchi N, Saito K, Arai G, Fujii Y, Kihara K.. Precise and simple placement of a prostatic stent under real-time transrectal ultrasonography monitoring. BJU Int. 2003.04; 91 (6): 577-578. ( PubMed )

  346. Okada Yohei, Fujii Yasuhisa, Moore Joseph P Jr, Winters Stephen J. Androgen receptors in gonadotrophs in pituitary cultures from adult male monkeys and rats. Endocrinology. 2003.01; 144 (1): 267-273. ( PubMed, DOI )

  347. Saito Kazutaka, Fujii Yashuhisa, Kasahara Ichiro, Kobayashi Nobuyuki, Kasuga Tsutomu, Kihara Kazunori. Malignant clear cell "sugar" tumor of the kidney: clear cell variant of epithelioid angiomyolipoma. J Urol. 2002.12; 168 (6): 2533-2534. ( PubMed, DOI )

  348. Kageyama Yukio, Kihara Kazunori, Yokoyama Minato, Sakai Yasuyuki, Koga Fumitaka, Saito Kazutaka, Yano Masataka, Arai Gaku, Hyochi Nobuhiko, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kobayashi Tsuyoshi. Endoscopic minilaparotomy partial nephrectomy for solitary renal cell carcinoma smaller than 4 cm. Jpn J Clin Oncol. 2002.10; 32 (10): 417-421. ( PubMed )

  349. Fujii Yasuhisa, Okada Yohei, Moore Joseph P Jr, Dalkin Alan C, Winters Stephen J. Evidence that PACAP and GnRH down-regulate follicle-stimulating hormone-beta mRNA levels by stimulating follistatin gene expression: effects on folliculostellate cells, gonadotrophs and LbetaT2 gonadotroph cells. Mol Cell Endocrinol. 2002.06; 192 (1-2): 55-64. ( PubMed )

  350. Kawakami Satoru, Fujii Yasuhisa, Okada Yohei, Winters Stephen J. Paracrine regulation of FSH by follistatin in folliculostellate cell-enriched primate pituitary cell cultures. Endocrinology. 2002.06; 143 (6): 2250-2258. ( PubMed, DOI )

  351. Kawakami Satoru, Arai Gaku, Hayashi Tetsuo, Fujii Yasuhisa, Xia Guangbin, Kageyama Yukio, Kihara Kazunori. PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro. J Cell Physiol. 2002.06; 191 (3): 310-319. ( PubMed, DOI )

  352. Kageyama Yukio, Kihara Kazunori, Ishizaka Kazuhiro, Okuno Tetsuo, Kawakami Satoru, Fujii Yasuhisa, Masuda Hitoshi, Suzuki Masahito, Hyochi Nobuhiko, Arai Gaku, Saito Kazutaka, Sakai Yasuyuki. Endoscope-assisted minilaparotomy (endoscopic minilaparotomy) for retroperitoneal Schwannoma: experience with three cases. Jpn J Clin Oncol. 2002.05; 32 (5): 177-180. ( PubMed )

  353. Kawakami S, Fujii Y, Winters SJ.. Follistatin production by skin fibroblasts and its regulation by dexamethasone. Mol Cell Endocrinol. 2001.02; 172 (1-2): 157-167. ( PubMed )

  354. Kawakami S, Kageyama Y, Fujii Y, Kihara K, Oshima H. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells. Anticancer Res. 2001.01; 21 (1A): 213-219. ( PubMed )

  355. Fujii Y, Yoshida M, Chien L J, Kihara K, Kageyama Y, Yasukochi Y, Oshima H. Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium. Urol Int. 2000; 64 (3): 129-133. ( PubMed, DOI )

  356. Fujii Y, Fukui I, Kihara K, Tsujii T, Kageyama Y, Oshima H. Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. Eur Urol. 1999.10; 36 (4): 309-313. ( PubMed, DOI )

  357. Fujii Y, Kageyama Y, Kawakami S, Kihara K, Oshima H.. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res. 1999.07; 90 (7): 753-757. ( PubMed )

  358. Arisawa C, Kihara K, Fujii Y, Ishizaka K, Masuda H, Oshima H. Possible misinterpretation on computed tomography of left inferior vena cava as retroperitoneal lymph node metastasis: a report of two cases. Int J Urol. 1999.04; 6 (4): 215-218. ( PubMed )

  359. Matsuoka Y, Fujii Y, Akashi T, Gosehi N, Kihara K. Primitive neuroectodermal tumour of the adrenal gland. BJU Int. 1999.03; 83 (4): 515-516. ( PubMed )

  360. Fujii Y, Fukui I, Kihara K, Tsujii T, Ishizaka K, Kageyama Y, Kawakami S, Oshima H.. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998.05; 33 (5): 464-468. ( PubMed )

  361. Fujii Y, Kihara K, Tsujii T, Kawakami S, Nemoto T, Washizuka M, Oshima H. Chromophobe cell renal carcinoma in childhood. Int J Urol. 1998.01; 5 (1): 92-93. ( PubMed )

  362. Kageyama Y, Kawakami S, Fujii Y, Kihara K, Oshima H.. Bacillus Calmette-Guérin enhances production and secretion of type IV collagenases in peripheral blood mononuclear cells. Jpn J Cancer Res. 1997.03; 88 (3): 281-288. ( PubMed )

  363. Tosaka A, Fujii Y, Oka K. Evaluation of transrectal voiding ultrasonography in men with micturition difficulties without apparent organic obstruction of the lower urinary tract. Eur Urol. 1997; 32 (4): 420-424. ( PubMed )

  364. Fujii Y, Higashi Y, Owada F, Okuno T, Mizuno H, Mizuno H. Magnetic resonance imaging for the diagnosis of prostate cancer metastatic to bone. Br J Urol. 1995.01; 75 (1): 54-58. ( PubMed )

  365. Fujii Y, Ajima J, Oka K, Tosaka A, Takehara Y. Benign renal tumors detected among healthy adults by abdominal ultrasonography. Eur Urol. 1995; 27 (2): 124-127. ( PubMed )

  366. Hirokawa M, Iwamoto T, Asakura S, Masuda M, Iwasaki A, Ikeda I, Fujii Y. Clinical study of infertile males with varicocele showing no typical radionuclide blood pooling on dynamic image of scrotal scintigraphy. Urology. 1991.06; 37 (6): 562-567. ( PubMed )

▼display all

Books etc 【 display / non-display

  1. Kazunori Kihara, Yasuhisa Fujii, Kazutaka Saito, Fumitaka Koga, Noboru Numao, Yoh Matsuoka, Junichiro Ishioka, Minato Yokoyama, Hitoshi Masuda, Tatsuya Nagai, Soichiro Yoshida, Manabu Tatokoro, Toshiki Kijima, Naoko Kawamura, Masaharu Inoue, Masaya Ito. Gasless Single-Port RoboSurgeon Surgery in Urology. Springer, 2015.09 (ISBN : 978-4-431-54504-0)

  2. Kazunori Kihara, Yasuhisa Fujii, Satoru Kawakami, Hitoshi Masuda, Fumitaka Koga, Kazutaka Saito, Noboru Numao, Yoh Matsuoka and Yasuyuki Sakai. Gasless Single Port Surgery for Renal Cell Carcinoma: Minimum Incision Endoscopic Surgery / Emerging Research and Treatments in Renal Cell Carcinoma. Edited by Robert Amato. InTech, 2012.02 (ISBN : 978-953-51-0022-5)

  3. Hitoshi Masuda, Kazunori Kihara, Yasuhisa Fujii, Fumitaka Koga, Kazutaka Saito, Mizuaki Sakura, Yohei Okada and Satoru Kawakami. Renal Cell Carcinoma in Dialysis Patients with End Stage Renal Disease: Focus on Surgery and Pathology. / Hemodialysis - Different Aspects. Edited by Maria Gorettil Penido. InTech, 2011.11 . (ISBN : 978-953-307-315-6)

Conference Activities & Talks 【 display / non-display

  1. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  2. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  3. Ishikawa Y, Uehara S, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  4. Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  5. Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  6. Izumi H, Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. Cribriform cancer is equally visible to non-cribriform cancer on multiparametric MRI: An analysis using texture features. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  7. Fukuda S, Tanaka H, Tanabe K, Tamiya T, Kobayashi M, Yajima S, Nakamura Y, Fujiwara M, Ishikawa Y, Yamamoto T, Araki S, Yoshida S, Yokoyama M, Matsuoka Y, Otsuka Y, Koga F, Fujii Y. Local recurrence following partial nephrectomy in patients with renal cell carcinoma: a multicenter study. The 117th annual meeting of the American Urological Association 2022.05.13 New Orleans, USA

  8. Kobayashi M, Matsuoka Y, Uehara S, Tanaka Hiroshi, Nakamura Y, Uchida Y, Fukuda S, Tanaka Hajime, Yoshida S, Yokoyama M, Fujii Y. PIRADS score combined with positive core number on MRI-ultrasound fusion targeted prostate biopsy can predict the absence of pathological extraprostatic extension. AUA Annual Meeting 2022.05.13

  9. Uchida Y, Yokoyama M, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. ASSESSMENT OF ERECTILE AND EJACULATORY FUNCTIONS AFTER BLADDER-SPARING THERAPY AGAINST MUSCLE-INVASIVE BLADDER CANCER. the 22nd World Meeting of the International Society for Sexual Medicine 2022.05

  10. 藤井靖久. [Utility and safety of 5-aminolevulinic acid in transurethral resection of the bladder tumor: real-world experience]. The 37th KOREA-JAPAN Urological Congress 2021.10.29

  11. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who benefits from extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Stereological analysis of biopsy-proven cancer sites. The 35th Annual Congress of the European Association of Urology 2020.07.17 Amsterdam Netherlands.

  12. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who needs extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Spatial analysis of biopsy-proven cancer sites. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  13. Matsuoka Y, Ishioka J, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Saito K, Fujii Y. Apparent diffusion coefficient ratio as a quantitative imaging marker: Utility in a nomogram for predicting biochemical recurrence after radical prostatectomy. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  14. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target sampling in addition to intra-target sampling for the detection of prostate cancer upgrading according to PIRADS scores. 12th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2020.02.09 Washington DC, USA

  15. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: a multi-institutional study.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

  16. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing’s syndrome. The 35th Annual European Association of Urology Congress Virtual, July 2020 2020

  17. Moriyama S, Yokoyama M, Nakamura Y, Fukuda S, Fukushima H, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of nocturia on deteriorated renal function after adrenalectomy in patients with primary aldosteronism. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  18. Ito T, Yoshida S, Taniguchi N, Sugimoto M, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. The utility of mixed reality model projection in ultrasound training for medical students.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  19. Yoshida S, Takahara T, Ishii C, Nakagawa K, Toda K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  20. Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  21. Yoshida S, Taniguchi N, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  22. Matsumoto S, Yoshida S, Yamada I, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Tateishi U, Fujii Y. Utility of diffusion-weighted MRI radiomics features in differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

  23. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  24. Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Novel classification model of tumour shape irregularity: significance for predicting potential oncologic risks in clinically localised renal cell carcinoma. The 35th Annual Congress of the European Association of Urology, 2020 (Virtual) 2020

  25. Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  26. Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise diagnostic algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  27. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal change in urinary incontinence, lower urinary tract symptoms and quality of life after artificial urinary sphincter implantation. 114th annual meeting of the American Urological Association 2020 Washington DC, USA

  28. Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Low incidence of perioperative infections without antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: a prospective single-institutional study of 1339 patients. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

  29. Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

  30. Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Abe Y, Takemura Y, Fujii Y. Relationship between nocturia and whole-body fluid distribution assessed by bioelectrical impedance. The 115th annual meeting of the American Urological Association 2020

  31. Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Feasibility of non-use of antimicrobial prophylaxis in clean urologic surgeries for adrenal and renal tumors: A prospective single-institutional study of 1339 patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam Netherlands

  32. Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: A multi-institutional study. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

  33. Fukushima H, Kijima T, Uehara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Previous chemoradiotherapy may enhance the efficacy of pembrolizumab in advanced urothelial carcinoma patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

  34. Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Significance of tumor shape irregularity for predicting potential oncologic risks in clinically localized renal cell carcinoma. The 114th Annual Meeting of the American Urological Association, 2020 (Virtual) 2020

  35. Yoshida S, Taniguchi N, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  36. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores near targets are of value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction.. The 12th international symposium on focal therapy and imaging in prostate and kidney cancer, 2020 2020 Washington DC, USA

  37. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores apart from targets are of limited value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  38. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores away from targets are of limited value for the detection of significant cancer: Analysis of 3D prostate biopsy mapping using multiplanar MRI reconstruction.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  39. Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. 113th annual meeting of the American Urological Association 2019.05.06 Chicago, USA.

  40. Matsuoka Y, Tanaka H,Kimura T, Moriyama S, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M,Ishioka J, Saito K, Fujii Y.. Usefulness of apparent diffusion coefficient ratio between tumor andnontumor as an imaging biomarker for prostate cancer.. The 114th annual meeting of the AmericanUrological Association, 2019.05.06 Chicago, USA

  41. Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.Matsuoka Y., Saito K., Fujii Y. ,. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosisin muscle-invasive bladder cancer patients treated with chemoradiation-basedbladder sparing protocol.. 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  42. Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Impact of bladder neck involvement and positive urine cytology in substratifying intermediate-risk non-muscle-invasive bladder cancer patients based on the prediction of high-risk recurrence. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  43. Fukushima H., Saito K., Yasuda Y., Tanabe K., Toide M., Fukuda S., Yokoyama M., Ishioka J., Matsuoka Y., Patil D., Cotta B., Patel S., Master V., Derweesh I., Fujii Y. . Prognostic impact of sex in non-metastatic clear cell renal cell carcinoma patients undergoing curative surgery: a multi-national study. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  44. Matsuoka Y, Uehara S, Yoshida S, Tanabe K, Tanaka H, Kimura T, Moriyama S,Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who benefits additionally from concurrent systematic biopsy at the time ofMRI-ultrasound fusion targeted biopsy to detect significant prostate cancer?. The 114th annual meeting of the American Urological Association 2019.05.04 Chicago,USA

  45. Yoshida S., Fukuda S., Moriyama S., Yokoyama M., Taniguchi N., Shinjo K., Sugimoto M., Saito K., Fujii Y.. Holographic surgical planning of partial nephrectomy using a wearable mixed reality computer. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA.

  46. T.Kijima,S.Fukuda,H.Fukushima,S.Moriyama,Y.Fujii. Impact of multimodal salvage therapy on survival in patients with recurrent adrenocortical carcinoma . European Urology Supplements 2019.04 Spain

  47. Moriyama S., Yokoyama M., Kawamura N., Tanabe K., Fujiwara M., Toide M., Saito K., Okuno T., Nomura J., Fujii Y.. Laparoscopic characteristics of Douglas’ pouch predicting difficult posterior dissection during laparoscopic sacrocolpopexy.. The 6th Annual Meeting of the Asia-Pacific Urogynecology Association 2019.03.23 Okinawa

  48. Kijima T., Fukuda S., Fukushima H., Moriyama S.,Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y.,Saito K., Fujii Y.. Impact of multimodal salvage therapy on survival in patients with recurrent adrenocortical carcinoma.. The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain.

  49. Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.,Matsuoka Y., Saito K., Fujii Y.. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder sparing protocol. . The 34th Annual Congress of the EuropeanAssociation of Urology 2019.03.18 Barcelona, Spain

  50. Fukushima H., Kijima T., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Tetra-modality bladder sparing therapy can be a viable treatment option for muscle-invasive bladder cancer patients with sarcopenia. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  51. Fukushima H., Saito K., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Kihara K., Koga F., Okuno T., Arisawa C., Kamata S., Nagahama K., Masuda H., Yonese J., Kageyama Y., Noro A., Tsujii T., Morimoto S., Fujii Y.. Obesity-specific effect of sex on prognosis of upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy: A Japanese multicenter study.. The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain.

  52. Fukushima H., Saito K., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Kihara K., Koga F., Okuno T., Arisawa C., Kamata S., Nagahama K., Masuda H., Yonese J., Kageyama Y., Noro A., Tsujii T., Morimoto S., Fujii Y. . Obesity-specific effect of sex on prognosis of upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy: A Japanese multicenter study. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  53. Fukushima H., Saito K., Yasuda Y., Tanabe K., Toide M., Fukuda S., Yokoyama M., Ishioka J., Matsuoka Y., Patil D., Cotta B., Patel S., Master V., Derweesh I., Fujii Y.. Impact of sex on prognosis of non-metastatic clear cell renal cell carcinoma patients undergoing curative surgery: An inverse probability of treatment weighting analysis. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  54. Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.,Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Clinical outcomes of muscle-invasive bladder cancer patients withhydronephrosis treated with tetramodality bladder sparing therapyincorporating consolidative partial cystectomy. . The34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain

  55. Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y.. Loco-regional radiotherapy targeting oligo-progressive lesions in castration-resistant prostate cancer patients: Intra-pelvic localized progressive lesions are the good targets. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  56. Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Substratification of intermediate-risk non-muscle-invasive bladder cancer based on the prediction of high-risk recurrence: Impact of bladder neck involvement and positive urine cytology. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  57. Kasumi Kaneko, Soichiro Yoshida, Yuki Arita, Kouhei Yamamoto, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain.

  58. Yoshida S., Fukuda S., Moriyama S., Yokoyama M., Taniguchi N., Shinjo K., Sugimoto M., Saito K., Fujii Y. . Holographic surgical planning of partial nephrectomy using a wearable mixed reality computer. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  59. Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

  60. Uchida Y., Yoshida S., ShimodaH., TanakaH., SakamotoT., UeharaS., YasudaY.,KijimaT., YokoyamaM., IshiokaJ., MatsuokaY., SaitoK., Fujii Y.. Differentiation of chromophobe renal cell carcinoma and renal oncocytomawith whole-lesion ADC analysis on diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

  61. J. Ishioka, M. Kobayashi、M. Fujiwara, N. Kawamura, T. Okuno, Y. Fukuda, T. Kohno, K. Kawano, S. Morimoto, S. Uehara, Y. Yasuda, T. Kijima, S. Yoshida, M. Yokoyama, M. Matsuoka, K. Saito, R. Saiki, I. Kumazawa, Y. Fujii.. Deep learning with a convolutional neural network algorithm for automated detetion of urinary tract stones using abdominal X-ray image. 34th European Association of Urology annual congress 2019.03.17 Barcelona, Spain

  62. Matsuoka Y, Tanaka H,Kimura T, Moriyama S, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M,Ishioka J, Saito K, Fujii Y. Apparent diffusion coefficient ratio between tumor and nontumor as apotential imaging biomarker for prostate cancer.. The 34th Annual Congress of the European 2019.03.16 Barcelona, Spain

  63. Matsuoka Y, Uehara S, Yoshida S, tanabe K, Tanaka H, KimuraT, Moriyama S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who gains additional benefits from systematic biopsy concurrently performedwith MRI-ultrasound fusion targeted biopsy in the detection of significantprostate cancer?. he 34th Annual Congress of the European Association of Urology, 2019.03.16 Barcelona, Spain

  64. S.Fukuda,K.Saito,Y.Ysuda,T.Soma,Y.Fijii. PT310:Early flare-response of C-reactive protein is associated with tumor shrinkage in patients with metastatic renal cell carcinoma treated with nivolumab. 2019.03

  65. M.Kobayashi,H,Msuda,M,Ito,Y.Waseda,Y.Fujii. 787:Artificial urinary sphincter implantation improves several storage and voiding symptoms in addition to urinary incontinence. 2019.03

  66. Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Clinical outcomes of muscle-invasive bladder cancer patients with hydronephrosis treated with tetramodality bladder sparing therapy incorporating consolidative partial cystectomy.. Genitourinary Cancers Symposium 2019.02.15 San Francisco, USA

  67. 木島敏樹、安田庸輔、上原翔、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. 筋層浸潤膀胱癌に対する4者併用膀胱温存療法(TUR+低用量化学放射線療法+膀胱部分切除):Histologic variantを有する症例での検討.. 日本泌尿器腫瘍研究会第4回学術集会 2018.10.20 横浜

  68. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. The role of MRI-targeted biopsy in prediction of adverse pathologicaland oncological outcome after radical prostatectomy. The 114th annual meeting of the American Urological Association 2018.05.20 San Francisco

  69. Kijima T., Prince T., Yoshida S., Yokoyama M, Ishioka J., MatsuokaY., Saito K., Kihara K., Neckers L., Fujii Y. . Novel therapy targeting androgen receptor splice variants by inhibiting heat shock factor 1 (HSF1) for the treatment of castration-resistant prostate cancer . 112nd annual meeting of the American Urological Association 2018.05.20 San Francisco, USA

  70. Yokoyama M, Kawamura N, Uehara S, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy.. The 113rd annual meeting of the American Urological Association 2018.05.19 San Francisco, USA

  71. 1 Yasuda Y, Saito K, Soma T, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. The outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. he outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. The 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

  72. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Saito K, Kihara K, Fujii Y. MRI-based risk assessment for postoperative biochemical recurrenceusing the Prostate Imaging Reporting and Data System (PI-RADS) scoresand capsular contact length. The 114th annual meeting of the American Urological Association 2018.05.18 San Francisco

  73. Junichiro Ishioka*, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Tomo Kimura, Kosei Kudo,Itsuo Kumazawa, Yasuhisa Fujii. Deep learning with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

  74. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Clinical significance of MRI-targeted biopsy for the risk stratification of oncological outcome after radical prostatectomy. 第106回日本泌尿器科学会総会 2018.04.19 京都

  75. 木島 敏樹, 吉田 宗一郎, 横山みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久.. 熱ショック因子(Heat shock factor 1: HSF1)阻害によるARスプライスバリアントを標的とした去勢抵抗性前立腺癌に対する新規治療.. 第106回日本泌尿器科学会総会 2018.04.19 京都

  76. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. The 33th European Association of Urology annual congress 2018.03.26 Copenhagen, Denmark

  77. Yajima S, Yoshida S, Takahara T,Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. The 18th annual meeting of the European Association of Urology 2018.03.19 Copenhagen, Denmark

  78. Yoshida S., Takahara T., Ishii C., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y. 935 METastasis Reporting And Data System for Prostate cancer (MET-RADS-P) score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. The 33th Annual Congress of the European Association of Urology 2018.03.19 Copenhagen, Denmark

  79. Yajima S, Yoshida S, Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  80. Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. . Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  81. Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  82. Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  83. Yoshida S, Takahara T, Ishii C, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . METastasis reporting and data system for prostate cancer score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  84. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  85. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  86. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  87. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  88. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  89. Soma T, Yoshida S, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . The usefulness of diffusion-weighted MRI in the differential diagnosis of urachal disorders. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  90. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  91. Fukushima H, Kobayashi M, Kwano K, Morimoto S. SOFA and quick SOFA are more clinically useful scoring systems than SIRS in predicting mortality of patients with acute pyelonephritis associated with upper urinary tract calculi. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.18 Copenhagen, Denmark

  92. Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Favorable locoregional control in patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy with lymph node dissection. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.18 Denmark

  93. Fukushima H, Kobayashi M, Kwano K, Morimoto S.. Lower performance status is a risk factor for sepsis of patients with acute pyelonephritis associated with upper urinary tract calculi in the Sepsis-3 era. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.18 Copenhagen, Denmark

  94. Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.17 Denmark

  95. Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Kimura T, Kudo K, Kumazawa I, Fujii Y. Computer-aided diagnosis with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.16 Denmark

  96. Yokoyama Minato, Koga Fumitaka, Otsuka Yukihiro,Tsukamoto Tetsuro, Okuno Tetsuo, Nagahama Katsushi, Kageyama Yukio, NoroAkira, Tsujii Toshihiko, Morimoto Shinji, Kitahara Satoshi, Kihara Kazunori,and Fujii Yasuhisa. Impact of chronic kidney disease and hypertension ondecline in remaining kidney function after radical nephrectomy. AUA Annual Meeting 2017 2017.05.15 Boston, USA

  97. Takayuki Nakayama, Toshiki Kijima, Soichiro Yoshida, Fumitaka Koga, Kazunori Kihara and Yasuhisa Fujii. Zoledronic acid sensitizes castration-resistant prostate cancer cells to radiotherapy and chemotherapy by downregulating STAT1. AUA Annual Meeting 2017 2017.05.15

  98. Yuma Waseda, Kazutaka Saito, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii. Predictive ability of renal cortex enhancement in dynamic CT for residual renal function after nephroureterectomy: Comparative study with renography.. AUA Annual Meeting 2017 2017.05.15 Boston

  99. Inoue M, Fujii Y, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K.. Incidence and risk factors of postoperative hypertension after partial nephrectomy for renal tumors. AUA Annual Meeting 2017 2017.05.14 Boston

  100. Yuma Waseda, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. New predictive scoring model for recurrence incorporating bladder neck involvement in patients with non-muscle-invasive bladder cancer.. AUA Annual Meeting 2017 2017.05.13 Boston

  101. Junichiro Ishioka, Yoh Matsuoka, Masaya Itoh, Masaharu Inoue, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Hiroshi Tanaka, Tomo Kimura, and Yasuhisa Fujii. Computer-aided diagnosis of prostate cancer using a deep neural networks algorithm in pre-biopsy multiparametric MRI.. AUA Annual Meeting 2017 2017.05.12 Boston

  102. Yosuke Yasuda1, Kazutaka Saito1, Naoko Kawamura1, Sho Uehara2, Takeshi Yuasa2, Minato Yokoyama1, Junichiro Ishioka1, Yoh Matsuoka1, Shinya Yamamoto2, Shunji Takahashi3, Tetsuo Okuno4, Junji Yonese2, Kazunori Kihara1 and Yasuhisa Fujii1. EARLY RESPONSE AT FOUR WEEKS OF C-REACTIVE PROTEIN PREDICTS SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS. 2017.05.12 Boston

  103. Nakamura Yuki, Tanaka Hajime, Fujii Yasuhisa, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. . 32nd Annual EAU Congress 2017.03.27 London, UK

  104. Matsuoka Yoh, Ishioka Junichiro, Tanaka Hiroshi, Kimura Tomo, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yoshida soichiro, Yokoyama Minato, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 32nd Annual EAU Congress 2017.03.27 London, UK

  105. Kawamura Naoko, Saito Kazutaka, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Adherent perinephric fat in Asian patients: predictors, andimpact on perioperative outcomes of partial nephrectomy. 32nd Annual EAU Congress 2017.03.27 London、UK

  106. Kawamura Naoko, Yokoyama Minato, Nakayama Takayuki, Tanaka Hajime, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori,Fujii Yasuhisa. Acute kidney injury after clampless partial nephrectomy:incidence, predictors, and its low impact on intermediate-term renalfunction . 32nd Annual EAU Congress 2017.03.27 London、UK

  107. Izumi Keita, Saito Kazutaka, Nakayama Takayuki, Fukuda Shohei, Fukushima Hiroshi, Uehara Sho, Koga Fumitaka, Yonese Junji, Kageyaam Yukio, Kihara Kazunori, Fujii Yasuhisa. Contact with renal sinus is a significant risk factor for metastasis in pT1 clear cell renal cell carcinoma. . 32nd Annual EAU Congress 2017.03.26 London, UK

  108. Matsuoka Y, Saito K, Numao N, Tanaka H, Inoue M, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Risk assessment for undertreatment in focal therapy and its applicability to intermediate- and high-risk prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

  109. Saito K, Matsuoka Y, Numao N, Hayashi K, Toda K, Ito M, Inoue M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Hemi-gland brachytherapy for localized prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

  110. 13.Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 San diego, USA

  111. Masaharu Inoue, Fumitaka Koga, Soichiro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Predictive model for therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiotherapy-based bladder-sparing protocol. AUA2016 Annual Meeting 2016.05.09 San Diego, USA

  112. Fujii Y et al.. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 USA

  113. 8.Ishioka J et al. Yokoyama M., Kawamura N., Fujii Y., Inoue M., Ishioka J., Numao N., Matsuoka Y., Saito K., Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K.. Longitudinal renal function recovery after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 San diego, USA

  114. Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 San diego, USA

  115. Fujiwara M et al.. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  116. Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  117. Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07

  118. Ishioka J et al.. The incidence of late bladder tumor recurrence of upper tract urothelial carcinoma and optimal cystoscopic follow-up: A multicenter study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego, USA

  119. Nakamura Y et al. . High specificity of diffusion-weighted MRI in differentiating residual bladder cancer from postoperative changes. 米国泌尿器科学会(annual meeting of the American Urological Association 2016.05.06 San diego, USA

  120. Nakamura Y et al.. Masked renal dysfunction in patients with adrenal Cushing's syndrome manifested by adrenalectomy. 米国泌尿器科学会(annual meeting of the American Urological Association 2016.05.06 San diego, USA

  121. Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego, USA

  122. Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

  123. 4.Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K, Kihara K.. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease.. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  124. 14.Yasuda Y, Saito K, Kawamura N, Yuasa T, Yokoyama M, Matsuoka Y, Ishioka J, Numao N, Okuno T, Yamamoto S, Takahashi S, Yonese J, Fujii Y, Kihara K. Prognostic significance of early CRP response for metastatic renal cell carcinoma treated with tyrosine kinase inhibitor. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  125. Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  126. Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  127. Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  128. 1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Germany

  129. Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Munich, Germany

  130. 5.Yokoyama M, Kawamura N, Fujii Y, Inoue M, Ishioka J, Numao N, Matsuoka Y, Saito K, Arisawa C, Okuno T, Noro A, Morimoto S, Kihara K. . Longitudinal changes in renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter study using a linear mixed model analysis. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Germany

  131. Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Munich, Germany

  132. Waseda Y. et al.. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13

  133. Ishioka J et al. When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancer. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  134. Fujiwara M et al.. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases. Munich, Germany 2016.03.12 Munich, Germany

  135. Tanaka H et al. Novel stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  136. Yoshida S et al. . Potential utility of standardized apparent diffusion coefficient value as a biomarker predicting clinical aggressiveness of bladder cancer with various MRI protocols at various institutions. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  137. Saito K, Matsuoka Y, Numao N, Hayashi K, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Focal therapy for prostate cancer with hemi-gland low dose rate brachytherapy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam

  138. Matsuoka Y, Numao N, Saito K, Tanaka H, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Eligibility analysis for focal therapy based on prostatectomy findings: Does intermediate-risk cancer have a higher likelihood of undertreatment than low-risk cancer?. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  139. Numao N, Ito M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Efficient sampling methods in systematic biopsy that could be performed in combination with MRI-guided biopsy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  140. 1.Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Recovery in renal function after radical nephrectomy and its negative predictive factors: a multicenter longitudinal study. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  141. Fujii Y., Kihara K., Tanaka H., Tatokoro M., Yoshida S. Yokoyama M., Ishioka J., Matusoka Y., Numao N., Saito K. Oncological and functional outcomes in muscle-invasive bladder cancer patients undergoing bladder-sparing treatment consisting of low-dose chemoradiotherapy and consolidative partial cystectomy. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  142. Yoshida S., Tanabe K., Koga F., Inoue M., Kobayashi S., Ishioka J., Tamura T., Sugawara E., Saito K., Akashi T., Fujii Y., Kihara K. Favorable survival outcomes after a chemoradiation-based multimodal approach against muscle-invasive bladder cancer with high Ki-67 expression. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  143. Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal MRI-targeted biopsy sampling number. The 111th annual meeting of the American Urological Association 2015.05.17

  144. Fujii, Y., Moriyama S., Yokoyama M., Yonese J., Noro A., Arisawa C., Morimoto S., Okuno T., Kitahara S., Koga F., Sakai Y., Suzuki M., Nagahama K., Izutani T., Saito K., Kihara K, TMDU NMIBC group.. Impact of bladder neck involvement on progression in patients with primary non-muscle-invasive bladder cancer: A multicenter validation study. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA

  145. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. Development of new three-dimensional image system for transurethral surgery. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA

  146. Yoshida S., Fukuda S., Kanda T., Fukui N., Saito K., Fujii Y., Kageyama Y, Kihara K. Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA,

  147. 7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative selection algorithm for eligible neoadjuvant chemotherapy patients in upper tract urothelial carcinomas. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  148. Tatokoro M., Nakanishi Y., Komai Y., Matsuoka Y., Ishioka J., Numao N., Yoshimoto K., Saito K., Fujii Y., Ogawa Y., Kihara K. Impact of impaired glucose tolerance on the development of hypoglycemia following removal of pheochromocytoma. 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  149. Tanaka H., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K., Yonese J., Kihara K. Development and validation of a novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  150. 8.Nakamura Y. , Numao N. , Yoshida S. , Komai Y. , Ito M. , Tatokoro M. , Yokoyama M. , Ishioka J. , Matsuoka Y. , Saito K. , Fujii Y. , Kihara K.. Transrectal 12-core prostate biopsy and MRI have a comparable risk of missing significant prostate cancer in men with PSA less than 10ng/ml and normal DRE. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  151. 2.Ishioka J, Yokoyama M, Waseda Y,Kawamura N, Itoh M, Tatokoro M, Yoshida S, Matsuoka Y,Numao N, Saito K, Arisawa C, Morimoto S, Kageyama Y,Fujii Y, Kihara K. Preoperative prediction of postoperative renal function for upper tract urothelial carcinoma patients: Concerning issues of perioperative renal impairment and the use of cisplatin-based chemotherapy. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  152. 3.Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Longitudinal change and risk factors of severe deterioration in renal function after radical nephrectomy. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  153. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Yokoyama M, Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. A novel three-dimensional image display system for transurethral surgery. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  154. Fujii, Y., Moriyama S., Yokoyama M., Yonese J., Noro A., Arisawa C., Morimoto S., Okuno T., Kitahara S., Koga F., Sakai Y., Suzuki M., Nagahama K., Izutani T., Saito K., Kihara K. Bladder neck involvement predicts progression in patients with primary non-muscle-invasive bladder cancer: A multicenter validation study. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  155. 5.Tanaka H, Fujii Y, Ito M, Tatokoro M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Yonese J, Kihara K. Novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  156. 7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative prediction algorithm for the selection of candidates for neoadjuvant chemotherapy in upper tract urothelial carcinomas. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  157. 6.Tatokoro M., Nakanishi Y., Komai Y., Matsuoka Y., Ishioka J., Numao N., Yoshimoto K., Saito K., Fujii Y., Ogawa Y., Kihara K. Impaired glucose tolerance predicts the development of hypoglycemia after removal of pheochromocytoma. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  158. Fujii, Y., Kihara, K., Numao, N., Matsuoka, Y., Ishioka, J., Saito, K. Gasless single-port RoboSurgeon partial cystectomy: A hybrid technique combining an intravesical and extravesical approach. The 30th Annual Congress of the European Association of Urology 2015.03.22

  159. 14.Fujii, Y., Kihara, K., Numao, N., Tanaka H., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K. Selective bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: oncological and functional outcome. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  160. 9.Nakayama T., Saito K., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N, Kihara K. Prognostic comparison of serum biomarkers for cancer-specific survival of renal cell carcinoma undergoing nephrectomy: C-reactive protein has the highest predictive ability on survival. The 30th Annual Congress of the European Association of Urology 2015.03.21

  161. 10.Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal number of sampling cores in MRI-targeted biopsy, Madrid. The 30th Annual Congress of the European Association of Urology 2015.03.21 Madrid, Spain

  162. Masaharu Inoue, Yasuhisa Fujii, Minato Yokoyama, Masaya Ito, Manabu Tatokoro, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Kazunori Kihara. Progression of hypertension after partial nephrectomy in Japanese patients with renal tumors. 30th Annual EAU Congress 2015.03.21 Madrid, Spain

  163. Yasuhisa Fujii, Kazunori Kihara. Gasless Single-port RoboSurgeon Surgery in Urology(Yasuhisa Fujii, Kazunori Kihara). TUDU CLS(Clinica Las Condes) joint meeting 2014.09.29 Santiago, Chile

  164. Yasuhisa Fujii. Case discussion with Dr. Hashim Uddin Ahmed. 第3回Metropolitan Urology Summer Seminar 2013.08.03 東京

  165. Yasuhisa Fujii. Video case discussion 1: Minimally invasive surgery - partial nephrectomy. 108th annual meeting of AUA (AUA 2013) 2013.05.05 San Diego

  166. Yasuhisa Fujii, Shinya Yamamoto, Junji Yonese, Hitoshi Masuda, Shinji Urakami, Shinichi, Kitsukawa, Kazunori Kihara, Iwao Fukui. Long-term results of the processus vaginalis transection method to prevent postradical prostatectomy inguinal hernia.. 108th annual meeting of AUA (AUA 2013) 2013.05.05 San Diego

  167. 藤井靖久. 分子標的時代におけるサイトカイン療法の位置づけ. 第101回日本泌尿器科学会総会 2013.04.28 札幌

  168. Robert Flanigan (moderator), Inderbir Gill, Marcus Quek, Shigeo Horie, Yasuhisa Fujii. Case-Based Discussion: Pitfalls of Radical Nephrectomy in the Management of Locally Advanced Cases of Renal Cancer. Advancements in Urology 2013: An AUA/JUA Symposium 2013.02.13 Las Vegas

  169. Yasuhisa Fujii. Case discussion with Prof. Mark Emberton. 第2回Metropolitan Urology Summer Seminar 2012.08.04 東京

▼display all

Awards & Honors 【 display / non-display

  • Poster Award: 30th Anniversary Congress of EAU (EAU 2015),European Association of Urology,2015.03

  • ENDO Travel Awards,2001.06